Clinical Informatics Market - Global Forecast to 2030
商品番号 : SMB-72163
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年1月 |
| ページ数 | 539 |
| 図表数 | 552 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | お問合せください |
| 種別 | 英文調査報告書 |
Report Overview
The global clinical informatics market is projected to reach 563.18 billion by 2030 from 231.45 billion in 2024, at a CAGR of 16.0% from 2024 to 2030.
世界の臨床情報学市場は、2024 年の 2,314 億 5 千万から 2030 年までに 5,631 億 8 千万に達し、2024 年から 2030 年までの CAGR は 16.0% になると予測されています。
The growth of the Clinical Informatics market is driven by growing Hospital-Acquired Infections, or HAIs. Hospital-acquired infections lead to severe health issues and eventually death in many patients during their stay in hospitals. Some of the common forms of HAI’s are as follows; bloodstream infections urinary tract infection, pneumonia, C. Difficile infections are highly prevalent in hospitals.
臨床情報学市場の成長は、院内感染（HAI）の増加によって推進されています。院内感染は重度の健康問題を引き起こし、最終的には入院中に多くの患者が死亡します。 HAI の一般的な形式のいくつかは次のとおりです。血流感染症、尿路感染症、肺炎、C. ディフィシル感染症は病院内で非常に蔓延しています。
The 2023 National and State Healthcare-Associated Infections (HAI) Progress Report shows that all the healthcare settings, from acute care hospitals to inpatient rehabilitation facilities and long-term acute care hospitals, have positive trends in decreasing healthcare-associated infections. In the US, the report shows that significant infections declined compared to 2022, including a 13% decline in CLABSI, an 11% decline in CAUTI, and a 5% decline in VAE. The increased adoption of EHRs also facilitates access to data and stimulates the need for more complex clinical informatics solutions. Moreover, rising chronical diseases such as cardiovascular diseases, obesity, and diabetes are the growth factors of the clinical informatics market.
“The telehealth solutions segment is projected to be the largest segment in the clinical clinical informatics market”
Based on the function segment, the telehealth solutions segment is projected to be the largest segment during the forecast period largely because of the changes brought on by the COVID-19 pandemic. A recent survey by Public Opinion Strategies for hims & hers in January 2024 found that 54% of Americans have used telehealth, with 89% of those users expressing satisfaction with their experience. This satisfaction rate has remained well over the past four years. Moreover, many Americans aware of the weight loss drug, such as Ozempic, support letting telehealth physicians prescribe the medications. Telehealth around the world for the government also works to increase growth in the clinical informatics market. There is also motivation through the WHO Global Strategy on Digital Health 2020-2025, Sláintecare Action Plan, HSE Corporate Plan, and Healthy Ireland government programs. This led to an increased need for enhancing the quality of care and the growing mergers of healthcare providers and more adoption of digital and connected healthcare technologies. consolidation among healthcare providers, and the rising adoption of digital and connected healthcare technologies.
“Cloud based deployment is the fastest segment in the clinical informatics market in 2023”
Cloud-based deployment is forecasted to be the fastest-growing part in the clinical informatics market in 2023, because this model has various benefits such as easy data integration from different cloud sources, unlimited access for users from remote places, low maintenance costs, high security, privacy, easy access, no need to buy hardware upfront, and great flexibility in capacity and resource use. Many applications offered by the cloud-based model, which cover accounting, performance monitoring, and communication through webmail and instant messaging, are helping this segment grow.
“APAC to witness the highest growth rate during the forecast period.”
The clinical informatics market is categorized into regions including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Of these, the Asia Pacific (APAC) region is expected to see the highest growth rate in the forecast periods. Market growth in the APAC region is mainly driven by factors such as the improving healthcare infrastructure, adoption of technology solutions and government initiatives for the adoption of clinical informatics solutions. For instance, the recent initiatives by the National Accreditation Board for Hospitals (NABH) to establish standards and guidelines for Hospital Information Systems (HIS) and Electronic Medical Records (EMR) are significantly driving the demand for healthcare technology solutions in India. Since launching these digital health standards in September 2023, 275 hospitals have already applied for certification, with 100 of them achieving it. This regulatory push is not only boosting the demand for clinical informatics solutions but is also helping India improve its healthcare delivery through better digital infrastructure.
The break-down of primary participants is as mentioned below:
- By Company Type – Tier 1: 45%, Tier 2: 35%, and Tier 3: 20%
- By Designation – C-level: 35%, Director-level: 25%, and Others: 40%
- By Region – North America: 45%, Europe: 30%, Asia Pacific: 20%, Latin America: 3%, and Middle East & Africa: 2%.
UnitedHealth Group. (US), Koninklijke Philips N.V. (Netherlands), and GE Healthcare (US) are some of the key players in the clinical informatics market.
- The study includes an in-depth competitive analysis of these key players in the clinical informatics market, with their company profiles, recent developments, and key market strategies.
Research Coverage
This research report categorizes the clinical informatics market by function (EHR, practice management systems, clinical workflow management, diagnostic and imaging solutions, clinical decision support systems, patient monitoring software, medication management, treatment focused specialty information system, telehealth & telemedicine, infection surveillance solutions, patient portals & patient engagement, population health management, data analytics and reporting solutions, mobile health applications, and HCIT integration & interoperability systems), by therapeutic area (oncology, cardiology, neurology, respiratory diseases, immunology, metabolic disorders, infectious diseases, and others (nephrology, urology, rare disease, hematology, gastroenterology, dermatology, ophthalmology, endocrinology, musculoskeletal disorders, mental health, and others), by component (software and services), by deployment (cloud based model, on premises model and hybrid model), by end users (hospitals, ambulatory surgical centers, ambulatory care centers, and other outpatient settings, specialty care centers, home healthcare, long-term care, & assisted living facilities, diagnostic & imaging centers, pharmacies, others (accountable care organization, management care organizations, and others) ),and by region (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the clinical informatics market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; Contracts, partnerships, agreements. new product & service launches, mergers and acquisitions, and recent developments associated with the clinical informatics market. Competitive analysis of upcoming startups in the clinical informatics market ecosystem is covered in this report.
Reasons to buy this report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the clinical informatics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
- Analysis of key drivers (growing telehealth and remote patient monitoring markets, government support for adopting it solutions, rising healthcare cost, increase in the adoption of ehr, growing pressure to reduce healthcare spending, and increase in demand for data driven decision making) restraints (complexity of big data in healthcare and lack of interoperability) opportunities (adavancement in real time data analysis, growth of mobile health (mhealth), growth of precision medicine & genomics, shift to value based care, growth of clincials assistants and rising economies of emerging countries)challenges (shortage of skilled it professionals and increasing number of data security issues) influencing the growth of the clinical informatics market.
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the clinical informatics market
- Market Development: Comprehensive information about lucrative markets – the report analyses the clinical informatics market across varied regions.
- Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the clinical informatics market
- Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like UnitedHealth Group (US), Koninklijke Philips N.V. (Netherlands), GE HealthCare (US), Cognizant (US), Oracle (US), Epic Systems Corporation. (US); among others in the clinical informatics market
Table of Contents
1 INTRODUCTION 41
1.1 STUDY OBJECTIVES 41
1.2 MARKET DEFINITION 41
1.3 STUDY SCOPE 42
1.3.1 SEGMENTS CONSIDERED & GEOGRAPHICAL SPREAD 42
1.3.2 INCLUSIONS & EXCLUSIONS 43
1.3.3 YEARS CONSIDERED 45
1.3.4 CURRENCY CONSIDERED 45
1.4 STAKEHOLDERS 46
2 RESEARCH METHODOLOGY 47
2.1 RESEARCH DESIGN 47
2.2 RESEARCH DATA 48
2.2.1 SECONDARY DATA 48
2.2.1.1 Key sources for secondary data 48
2.2.1.2 Key data from secondary sources 49
2.2.2 PRIMARY DATA 49
2.2.2.1 Key sources for primary data 50
2.2.2.2 Key objectives of primary research 50
2.2.2.3 Key data from primary sources 51
2.2.2.4 Key industry insights 52
2.2.2.5 Breakdown of primary interviews 52
2.3 MARKET SIZE ESTIMATION 53
2.3.1 SUPPLY-SIDE ANALYSIS 54
2.3.2 BOTTOM-UP APPROACH (END-USER ADOPTION) 56
2.3.3 TOP-DOWN APPROACH 57
2.3.4 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS 57
2.4 DATA TRIANGULATION 61
2.5 RESEARCH ASSUMPTIONS 62
2.5.1 MARKET SIZING ASSUMPTIONS 62
2.5.2 STUDY ASSUMPTIONS 62
2.6 RISK ASSESSMENT 63
2.7 RESEARCH LIMITATIONS 63
2.7.1 METHODOLOGY-RELATED LIMITATIONS 63
2.7.2 SCOPE-RELATED LIMITATIONS 63
3 EXECUTIVE SUMMARY 64
4 PREMIUM INSIGHTS 71
4.1 CLINICAL INFORMATICS MARKET OVERVIEW 71
4.2 CLINICAL INFORMATICS MARKET, BY END USER AND REGION 72
4.3 CLINICAL INFORMATICS MARKET: GEOGRAPHIC SNAPSHOT 73
4.4 CLINICAL INFORMATICS MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS 74
5 MARKET OVERVIEW 75
5.1 INTRODUCTION 75
5.2 MARKET DYNAMICS 75
5.2.1 DRIVERS 77
5.2.1.1 Increasing focus on telehealth & remote patient monitoring 77
5.2.1.2 Favorable government initiatives for adoption of IT solutions 79
5.2.1.3 Growing need to curb healthcare spending 80
5.2.1.4 Increasing adoption of EHR 81
5.2.1.5 Growing focus on data-driven decision-making 82
5.2.2 RESTRAINTS 82
5.2.2.1 Interoperability issues associated with information systems 82
5.2.2.2 High deployment costs 83
5.2.2.3 Resistance from conventional healthcare providers 84
5.2.3 OPPORTUNITIES 84
5.2.3.1 Gradual shift toward outpatient care environments 84
5.2.3.2 Potential benefits of real-world evidence 85
5.2.3.3 Development of mHealth tools 86
5.2.3.4 Emergence of precision medicine and utilization of omics data sets 87
5.2.3.5 Emphasis on value-based medicine 88
5.2.3.6 Uptake of virtual clinical & nursing assistants 89
5.2.3.7 High-growth potential of emerging economies 90
5.2.4 CHALLENGES 91
5.2.4.1 Shortage of skilled IT professionals 91
5.2.4.2 Data security concerns 91
5.2.4.3 Complexities associated with big data in healthcare 95
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 95
5.4 INDUSTRY TRENDS 96
5.4.1 INTEROPERABILITY & INTEGRATED CARE MODELS 96
5.4.2 CLOUD-BASED SOLUTIONS 97
5.4.3 BIG DATA IN HEALTHCARE 98
5.5 ECOSYSTEM ANALYSIS 99
5.6 VALUE CHAIN ANALYSIS 102
5.7 TECHNOLOGY ANALYSIS 103
5.7.1 KEY TECHNOLOGIES 103
5.7.1.1 Predictive analytics 103
5.7.1.2 Artificial intelligence & machine learning 104
5.7.1.3 Virtual assistants & chatbots 104
5.7.1.4 Augmented & virtual reality 104
5.7.2 COMPLEMENTARY TECHNOLOGIES 105
5.7.2.1 Real-world evidence data 105
5.7.2.2 EHR-integration 105
5.7.2.3 Digital health platforms 105
5.7.2.4 Clinical data warehousing & big data analytics 106
5.7.2.5 Digital pathology 106
5.7.3 ADJACENT TECHNOLOGIES 107
5.7.3.1 Cloud computing 107
5.7.3.2 Blockchain technology 107
5.7.3.3 IoT & wearables 107
5.7.3.4 Genomics & precision medicine platforms 107
5.8 REGULATORY ANALYSIS 108
5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, & OTHER ORGANIZATIONS 108
5.8.2 REGULATORY SCENARIO 111
5.8.2.1 North America 111
5.8.2.2 Europe 113
5.8.2.3 Asia Pacific 113
5.8.2.4 Middle East & Africa 115
5.8.2.5 Latin America 115
5.9 PRICING ANALYSIS 115
5.9.1 INDICATIVE PRICE OF CLINICAL INFORMATICS SOLUTIONS,
BY FUNCTION (2023) 116
5.9.1.1 Average selling price of EHR solutions, by key player (2023) 116
5.9.1.2 Indicative price of EHR solutions, by component (2023) 117
5.9.1.3 Indicative price of clinical decision support systems, by product (2023) 117
5.9.1.4 Indicative price of HCIT integration solutions, by component (2023) 118
5.9.2 INDICATIVE PRICE OF CLINICAL INFORMATICS SOLUTIONS, BY REGION (2023) 119
5.10 PORTER’S FIVE FORCES ANALYSIS 120
5.10.1 INTENSITY OF COMPETITIVE RIVALRY 122
5.10.2 BARGAINING POWER OF BUYERS 122
5.10.3 THREAT OF SUBSTITUTES 122
5.10.4 THREAT OF NEW ENTRANTS 122
5.10.5 BARGAINING POWER OF SUPPLIERS 122
5.11 KEY STAKEHOLDERS AND BUYING CRITERIA 123
5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS 123
5.11.2 KEY BUYING CRITERIA 124
5.12 PATENT ANALYSIS 124
5.12.1 PATENT PUBLICATION TRENDS 124
5.12.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES
FOR CLINICAL INFORMATICS 125
5.12.3 LEADING PATENTS IN CLINICAL INFORMATICS MARKET 127
5.13 END-USER ANALYSIS 130
5.13.1 UNMET NEEDS 130
5.13.2 END-USER EXPECTATIONS 131
5.14 KEY CONFERENCES & EVENTS, 2024–2025 132
5.15 CASE STUDY ANALYSIS 133
5.15.1 TRANSFORMING CLINICAL INFORMATICS AT CORNWALL COMMUNITY HOSPITAL 133
5.15.2 GRANGER MEDICAL CLINIC’S FOCUS ON GAINING EFFICIENT HEALTHCARE OPERATIONS 134
5.15.3 IMPROVEMENTS IN IMAGING EFFICIENCY BY OVERCOMING REPORTING & VISUALIZATION BARRIERS 135
5.16 INVESTMENT & FUNDING SCENARIO 136
5.17 BUSINESS MODELS 136
5.18 IMPACT OF AI/GEN AI IN CLINICAL INFORMATICS MARKET 137
5.18.1 KEY-USE CASES 139
5.18.2 CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION 139
5.18.2.1 Case Study 1: Enhancing diagnostic accuracy with AI solutions at Princess Alexandra Hospital 139
5.18.2.2 Case Study 2: Leveraging AI for proactive infection prevention in hospital 140
5.18.3 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 141
5.18.3.1 Healthcare IT Market 141
5.18.3.2 Clinical decision support system market 141
5.18.3.3 Telehealth & telemedicine market 142
5.18.3.4 Ambulatory EHR market 142
5.18.4 USER READINESS & IMPACT ASSESSMENT 142
5.18.4.1 User readiness 142
5.18.4.1.1 User A: Hospitals 142
5.18.4.1.2 User B: Ambulatory surgery centers 142
5.18.4.2 Impact assessment 143
5.18.4.2.1 User A: Hospitals 143
5.18.4.2.1.1 Implementation 143
5.18.4.2.1.2 Impact 143
5.18.4.2.2 User B: Ambulatory surgery centers 143
5.18.4.2.2.1 Implementation 143
5.18.4.2.2.2 Impact 144
6 CLINICAL INFORMATICS MARKET, BY FUNCTION 145
6.1 INTRODUCTION 146
6.2 ELECTRONIC HEALTH RECORDS 148
6.2.1 NEED FOR INTEGRATED HEALTHCARE SYSTEMS TO FUEL UPTAKE 148
6.3 PRACTICE MANAGEMENT SYSTEMS 149
6.3.1 DIGITAL SHIFT IN MEDICAL PRACTICE MANAGEMENT TO SUPPORT ADOPTION IN HEALTHCARE ORGANIZATIONS 149
6.4 CLINICAL WORKFLOW MANAGEMENT SYSTEMS 150
6.4.1 WORKFLOW AUTOMATION SOLUTIONS 151
6.4.1.1 Patient flow management solutions 152
6.4.1.1.1 Patient flow management to improve resource utilization and prevent staff burnout by streamlining workflows 152
6.4.1.2 Clinician & staff scheduling solutions 154
6.4.1.2.1 Need for improved efficiency and reduced scheduling conflicts to augment segment growth 154
6.4.2 CLINICAL COMMUNICATION & COLLABORATION SOLUTIONS 155
6.4.2.1 Advantages in decision-making and process expediency to drive market 155
6.5 DIAGNOSTIC & IMAGING SOLUTIONS 156
6.5.1 MEDICAL IMAGE ANALYSIS SOFTWARE 157
6.5.1.1 Robust growth of 3D medical imaging systems and digitization of measurement values to support segment growth 157
6.5.2 PACS & VNA 158
6.5.2.1 Favorable government initiatives to modernize imaging facilities to spur segment growth 158
6.5.3 RADIOLOGY INFORMATION SYSTEMS 160
6.5.3.1 Focus on healthcare digitization and rising demand for efficient workflow optimization in healthcare facilities to drive segment 160
6.5.4 LABORATORY INFORMATION SYSTEMS 161
6.5.4.1 Rising demand for accurate and efficient lab test results to fuel market growth 161
6.6 CLINICAL DECISION SUPPORT SYSTEMS 162
6.6.1 SUPPORT IN DEVELOPING BETTER TREATMENT PLANS TO DRIVE ADOPTION 162
6.7 MEDICATION MANAGEMENT SYSTEMS 163
6.7.1 EPRESCRIBING SOLUTIONS 165
6.7.1.1 Ability to link and search patient records and easy access to patient information to boost market growth 165
6.7.2 COMPUTERIZED PHYSICIAN ORDER ENTRY SYSTEMS 166
6.7.2.1 Need for minimizing prescription and drug administration errors to drive segment 166
6.7.3 PHARMACY INFORMATION SYSTEMS 167
6.7.3.1 Pharmacy information systems to reduce medication dispensing error rates and ensure efficient inventory control 167
6.8 SPECIALTY INFORMATION MANAGEMENT SOLUTIONS 168
6.8.1 ONCOLOGY INFORMATION SYSTEMS 169
6.8.1.1 Rise in cancer prevalence and technological advancements in oncology treatments to support market growth 169
6.8.2 CARDIOVASCULAR INFORMATION SYSTEMS 170
6.8.2.1 Increasing incidence of cardiovascular diseases to
propel market growth 170
6.8.3 OTHER SPECIALITY INFORMATION MANAGEMENT SOLUTIONS 171
6.9 TELEHEALTH & TELEMEDICINE SOLUTIONS 172
6.9.1 SHORTAGE OF HEALTHCARE WORKFORCE AND NEED FOR REMOTE PATIENT MONITORING TO ACCELERATE ADOPTION 172
6.10 INFECTION SURVEILLANCE SOLUTIONS 173
6.10.1 INCREASING PREVALENCE OF HOSPITAL-ACQUIRED INFECTIONS
TO AID MARKET GROWTH 173
6.11 PATIENT PORTALS & ENGAGEMENT SOLUTIONS 174
6.11.1 BETTER PERSONALIZED MEDICATION PLANS AND STREAMLINED FOLLOW-UP CARE TO SUPPORT MARKET GROWTH 174
6.12 POPULATION HEALTH MANAGEMENT SOLUTIONS 175
6.12.1 POPULATION HEALTH MANAGEMENT SOLUTIONS TO REDUCE READMISSIONS AND TRACK CARE ACROSS MULTIPLE SPECIALTIES 175
6.13 DATA ANALYTICS & REPORTING SOLUTIONS 176
6.13.1 NEED FOR ENHANCED PATIENT CARE AND STREAMLINED OPERATIONS TO FUEL UPTAKE 176
6.14 MOBILE HEALTH APPLICATIONS 177
6.14.1 RISING PREFERENCE FOR SELF-CARE MANAGEMENT TO BOOST MARKET GROWTH 177
6.15 HCIT INTEGRATION & INTEROPERABILITY SYSTEMS 178
6.15.1 NEED TO REPLACE OUTDATED MEDICAL TECHNOLOGY AND REDUCE HEALTHCARE COSTS TO PROPEL MARKET GROWTH 178
6.16 OTHER FUNCTIONS 179
7 CLINICAL INFORMATICS MARKET, BY DEPLOYMENT MODEL 181
7.1 INTRODUCTION 182
7.2 CLOUD-BASED MODEL 182
7.2.1 POTENTIAL SCALABILITY AND COST-EFFECTIVENESS TO DRIVE MARKET 182
7.3 ON-PREMISE MODEL 184
7.3.1 GROWING DEMAND FOR SECURITY, CONTROL, AND COMPLIANCE NEEDS TO DRIVE MARKET 184
7.4 HYBRID MODELS 185
7.4.1 RISING ADOPTION OF HYBRID CLOUD MODELS TO ENHANCE INNOVATION, SCALABILITY, AND DATA SECURITY 185
8 CLINICAL INFORMATICS MARKET, BY COMPONENT 187
8.1 INTRODUCTION 188
8.2 SOFTWARE 188
8.2.1 STANDALONE SOFTWARE 191
8.2.1.1 Rising focus on data management efficiency to drive market 191
8.2.2 INTEGRATED SOFTWARE 192
8.2.2.1 Ability to create cohesive unification among multiple platforms to fuel uptake 192
8.3 SERVICES 193
8.3.1 RISING REQUIREMENT FOR CONSULTING & IMPLEMENTATION SERVICES
TO DRIVE MARKET 193
9 CLINICAL INFORMATICS MARKET, BY THERAPEUTIC AREA 197
9.1 INTRODUCTION 198
9.2 ONCOLOGY 198
9.2.1 RISING ADOPTION OF ELECTRONIC MEDICAL RECORDS TO DRIVE MARKET 198
9.3 CARDIOLOGY 201
9.3.1 ADVANCES IN AI-ENHANCED DIAGNOSTIC IMAGING AND DECISION SUPPORT TO PROPEL DEMAND 201
9.4 NEUROLOGY 202
9.4.1 CHALLENGES IN TREATING AND RESEARCHING NEUROLOGICAL DISORDERS TO DRIVE ADOPTION 202
9.5 RESPIRATORY DISEASES 203
9.5.1 ADVANCES IN IMAGING SOLUTIONS FOR RESPIRATORY DIAGNOSTICS TO PROPEL MARKET 203
9.6 IMMUNOLOGY 204
9.6.1 POTENTIAL FOR ENHANCING DETECTION AND PERSONALIZED THERAPEUTICS TO PROPEL ADOPTION 204
9.7 METABOLIC DISORDERS 205
9.7.1 RISING INCIDENCE OF DIABETES AND LIVER DISEASES TO DRIVE DEMAND 205
9.8 INFECTIOUS DISEASES 206
9.8.1 NEED TO MANAGE AND REDUCE SPREAD OF INFECTIOUS DISEASES TO SUPPORT MARKET GROWTH 206
9.9 OTHER THERAPEUTIC AREAS 207
10 CLINICAL INFORMATICS MARKET, BY END USER 210
10.1 INTRODUCTION 211
10.2 HOSPITALS 212
10.2.1 IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE FOR DIGITAL INFORMATICS TO DRIVE MARKET 212
10.3 AMBULATORY SURGERY CENTERS, AMBULATORY CARE CENTERS, AND OTHER OUTPATIENT SETTINGS 213
10.3.1 ADVANTAGES OF COST-EFFICIENCY AND RAPID TURNAROUND TIMES TO PROPEL MARKET 213
10.4 SPECIALTY CARE CENTERS 214
10.4.1 INCREASING FOCUS ON PERSONALIZED THERAPEUTICS TO SUPPORT MARKET GROWTH 214
10.5 HOME HEALTHCARE, LONG-TERM CARE, AND ASSISTED LIVING FACILITIES 216
10.5.1 GROWING FOCUS ON TELEHEALTH TO FUEL UPTAKE 216
10.6 DIAGNOSTIC & IMAGING CENTERS 217
10.6.1 INCREASING UPTAKE OF ADVANCED IMAGING DIAGNOSTICS INTEGRATED WITH AI SOLUTIONS TO BOOST DEMAND 217
10.7 PHARMACIES 218
10.7.1 RISING REQUIREMENT FOR ELECTRONIC HEALTH RECORDS TO SUPPORT MARKET GROWTH 218
10.8 OTHER END USERS 220
11 CLINICAL INFORMATICS MARKET, BY REGION 221
11.1 INTRODUCTION 222
11.2 NORTH AMERICA 222
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 224
11.2.2 US 230
11.2.2.1 Vast healthcare infrastructure, reforms, and advancements in digital innovation to ensure strong market share 230
11.2.3 CANADA 237
11.2.3.1 Government investment in health infrastructure and adoption of digital solutions such as EHRs 237
11.3 EUROPE 243
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 243
11.3.2 UK 250
11.3.2.1 Growing digitalization of healthcare infrastructure to drive market 250
11.3.3 GERMANY 255
11.3.3.1 Favorable government initiatives to drive market 255
11.3.4 FRANCE 261
11.3.4.1 Strong government support and digitalization to propel market growth 261
11.3.5 ITALY 266
11.3.5.1 Increasing focus on optimizing healthcare resources to accelerate growth 266
11.3.6 SPAIN 272
11.3.6.1 Rising aging population and growing demand for healthcare to support adoption 272
11.3.7 REST OF EUROPE 277
11.4 ASIA PACIFIC 283
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 283
11.4.2 JAPAN 290
11.4.2.1 Well-established healthcare infrastructure and rapidly evolving mobile healthcare sector to drive growth 290
11.4.3 CHINA 295
11.4.3.1 Established healthcare reforms for EMR solutions to drive market 295
11.4.4 INDIA 301
11.4.4.1 Growing adoption of EHR solutions to fuel uptake 301
11.4.5 REST OF ASIA PACIFIC 307
11.5 LATIN AMERICA 313
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 314
11.5.2 BRAZIL 320
11.5.2.1 Brazil to dominate clinical informatics market in Latin America 320
11.5.3 MEXICO 325
11.5.3.1 Rising focus on digital health to boost market growth 325
11.5.4 REST OF LATIN AMERICA 330
11.6 MIDDLE EAST & AFRICA 336
11.6.1 INCREASING INVESTMENTS IN MODERNIZING HEALTHCARE SYSTEMS TO BOOST MARKET GROWTH 336
11.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 336
11.6.3 GCC COUNTRIES 342
11.6.3.1 Rising healthcare investments to fuel uptake 342
11.6.4 REST OF MIDDLE EAST & AFRICA 347
12 COMPETITIVE LANDSCAPE 353
12.1 OVERVIEW 353
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 353
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CLINICAL INFORMATICS MARKET 354
12.3 REVENUE ANALYSIS, 2019–2023 358
12.4 MARKET SHARE ANALYSIS, 2023 359
12.5 COMPANY VALUATION AND FINANCIAL METRICS 362
12.6 BRAND/SOFTWARE COMPARISON 364
12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 365
12.7.1 STARS 365
12.7.2 EMERGING LEADERS 365
12.7.3 PERVASIVE PLAYERS 365
12.7.4 PARTICIPANTS 365
12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 367
12.7.5.1 Company footprint 367
12.7.5.2 Region footprint 368
12.7.5.3 Function footprint 369
12.7.5.4 Component footprint 374
12.7.5.5 Deployment model footprint 375
12.7.5.6 End-user footprint 376
12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 377
12.8.1 PROGRESSIVE COMPANIES 377
12.8.2 RESPONSIVE COMPANIES 377
12.8.3 DYNAMIC COMPANIES 377
12.8.4 STARTING BLOCKS 377
12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 379
12.8.5.1 Detailed list of key startups/SMEs 379
12.8.5.2 Competitive benchmarking of startups/SMEs 380
12.9 COMPETITIVE SCENARIO 380
12.9.1 PRODUCT LAUNCHES/APPROVALS/UPGRADES 380
12.9.2 DEALS 383
12.9.3 EXPANSIONS 385
12.9.4 OTHER DEVELOPMENTS 386
13 COMPANY PROFILES 387
13.1 KEY PLAYERS 387
13.1.1 UNITEDHEALTH GROUP 387
13.1.1.1 Business overview 387
13.1.1.2 Products offered 388
13.1.1.3 Recent developments 391
13.1.1.3.1 Product launches/approvals/upgrades 391
13.1.1.3.2 Deals 391
13.1.1.4 MnM view 392
13.1.1.4.1 Right to win 392
13.1.1.4.2 Strategic choices 392
13.1.1.4.3 Weaknesses and competitive threats 392
13.1.2 ORACLE 393
13.1.2.1 Business overview 393
13.1.2.2 Products offered 395
13.1.2.3 Recent developments 398
13.1.2.3.1 Product launches/approvals/upgrades 398
13.1.2.3.2 Deals 400
13.1.2.3.3 Contracts 401
13.1.2.4 MnM view 402
13.1.2.4.1 Right to win 402
13.1.2.4.2 Strategic choices 402
13.1.2.4.3 Weaknesses and competitive threats 402
13.1.3 EPIC SYSTEMS CORPORATION 402
13.1.3.1 Business overview 402
13.1.3.2 Products offered 403
13.1.3.3 Recent developments 408
13.1.3.3.1 Product launches/approvals/upgrades 408
13.1.3.3.2 Deals 409
13.1.3.3.3 Contracts 410
13.1.3.4 MnM view 411
13.1.3.4.1 Right to win 411
13.1.3.4.2 Strategic choices 411
13.1.3.4.3 Weaknesses and competitive threats 411
13.1.4 KONINKLIJKE PHILIPS N.V. 412
13.1.4.1 Business overview 412
13.1.4.2 Products offered 414
13.1.4.3 Recent developments 416
13.1.4.3.1 Product launches/approvals/upgrades 416
13.1.4.3.2 Deals 417
13.1.4.4 MnM view 423
13.1.4.4.1 Right to win 423
13.1.4.4.2 Strategic choices 423
13.1.4.4.3 Weaknesses and competitive threats 423
13.1.5 MCKESSON CORPORATION 424
13.1.5.1 Business overview 424
13.1.5.2 Products offered 425
13.1.5.3 Recent developments 427
13.1.5.3.1 Deals 427
13.1.5.3.2 Expansions 428
13.1.5.4 MnM view 428
13.1.5.4.1 Right to win 428
13.1.5.4.2 Strategic choices 428
13.1.5.4.3 Weaknesses and competitive threats 429
13.1.6 GE HEALTHCARE 430
13.1.6.1 Business overview 430
13.1.6.2 Products offered 432
13.1.6.3 Recent developments 434
13.1.6.3.1 Product launches/approvals/upgrades 434
13.1.6.3.2 Deals 435
13.1.7 COGNIZANT 437
13.1.7.1 Business overview 437
13.1.7.2 Products offered 439
13.1.7.3 Recent developments 439
13.1.7.3.1 Product launches/approvals/upgrades 439
13.1.7.3.2 Deals 440
13.1.8 EXLSERVICE HOLDINGS, INC. 441
13.1.8.1 Business overview 441
13.1.8.2 Products offered 443
13.1.8.3 Recent developments 445
13.1.8.3.1 Deals 445
13.1.9 ECLINICALWORKS 446
13.1.9.1 Business overview 446
13.1.9.2 Products offered 446
13.1.9.3 Recent developments 448
13.1.9.3.1 Product launches/approvals/upgrades 448
13.1.9.3.2 Deals 448
13.1.10 MEDICAL INFORMATION TECHNOLOGY, INC. 450
13.1.10.1 Business overview 450
13.1.10.2 Products offered 450
13.1.10.3 Recent developments 451
13.1.10.3.1 Product launches/approvals/upgrades 451
13.1.10.3.2 Deals 452
13.1.10.3.3 Contracts 453
13.1.10.3.4 Other developments 455
13.1.11 SIEMENS HEALTHINEERS AG 456
13.1.11.1 Business overview 456
13.1.11.2 Products offered 458
13.1.11.3 Recent developments 459
13.1.11.3.1 Product launches/approvals/upgrades 459
13.1.11.3.2 Deals 459
13.1.12 TRUBRIDGE 462
13.1.12.1 Business overview 462
13.1.12.2 Products offered 464
13.1.12.3 Recent developments 465
13.1.12.3.1 Product launches/approvals/upgrades 465
13.1.12.3.2 Deals 465
13.1.12.3.3 Other developments 466
13.1.13 VERADIGM LLC 467
13.1.13.1 Business overview 467
13.1.13.2 Products offered 469
13.1.13.3 Recent developments 470
13.1.13.3.1 Deals 470
13.1.14 ADVANCEDMD, INC. 471
13.1.14.1 Business overview 471
13.1.14.2 Products offered 472
13.1.14.3 Recent developments 473
13.1.14.3.1 Product launches/approvals/upgrades 473
13.1.14.3.2 Other developments 474
13.1.15 ATHENAHEALTH, INC. 475
13.1.15.1 Business overview 475
13.1.15.2 Products offered 475
13.1.15.3 Recent developments 476
13.1.15.3.1 Product launches/approvals/upgrades 476
13.1.15.3.2 Deals 477
13.1.15.3.3 Contracts 479
13.1.16 MERATIVE 481
13.1.16.1 Business overview 481
13.1.16.2 Products offered 482
13.1.16.3 Recent developments 483
13.1.16.3.1 Product launches/approvals/upgrades 483
13.1.16.3.2 Deals 484
13.1.16.3.3 Other developments 484
13.1.17 NVIDIA CORPORATION 485
13.1.17.1 Business overview 485
13.1.17.2 Products offered 487
13.1.17.3 Recent developments 488
13.1.17.3.1 Product launches/approvals/upgrades 488
13.1.17.3.2 Deals 488
13.1.18 AGFA HEALTHCARE 490
13.1.18.1 Business overview 490
13.1.18.2 Products offered 490
13.1.18.3 Recent developments 491
13.1.18.3.1 Product launches/approvals/upgrades 491
13.1.18.3.2 Deals 491
13.1.19 NXGN MANAGEMENT, LLC 492
13.1.19.1 Business overview 492
13.1.19.2 Products offered 492
13.1.19.3 Recent developments 493
13.1.19.3.1 Product launches/approvals/upgrades 493
13.1.19.3.2 Deals 494
13.1.19.3.3 Expansions 495
13.1.19.3.4 Contracts 496
13.1.20 INTERSYSTEMS CORPORATION 498
13.1.20.1 Business overview 498
13.1.20.2 Products offered 499
13.1.20.3 Recent developments 500
13.1.20.3.1 Product launches/approvals/upgrades 500
13.1.20.3.2 Deals 501
13.1.21 DEDALUS S.P.A. 502
13.1.21.1 Business overview 502
13.1.21.2 Products offered 502
13.1.21.3 Recent developments 503
13.1.21.3.1 Deals 503
13.1.22 IQVIA INC. 505
13.1.22.1 Business overview 505
13.1.22.2 Products offered 507
13.1.22.3 Recent developments 508
13.1.22.3.1 Product launches/approvals/upgrades 508
13.1.23 SAS INSTITUTE INC. 509
13.1.23.1 Business overview 509
13.1.23.2 Products offered 509
13.1.23.3 Recent developments 510
13.1.23.3.1 Product launches/approvals/upgrades 510
13.1.23.3.2 Deals 510
13.1.24 WIPRO 511
13.1.24.1 Business overview 511
13.1.24.2 Products offered 513
13.1.24.3 Recent developments 514
13.1.24.3.1 Deals 514
13.1.25 HEALTH CATALYST 515
13.1.25.1 Business overview 515
13.1.25.2 Products offered 516
13.1.25.3 Recent developments 517
13.1.25.3.1 Deals 517
13.2 OTHER PLAYERS 518
13.2.1 TEMPUS 518
13.2.2 PRACTICE FUSION, INC. 519
13.2.3 MEDEANALYTICS, INC. 520
13.2.4 MEDECISION 521
13.2.5 CHARTIS 522
13.2.6 ALLARA HEALTH 523
13.2.7 SURGICAL INFORMATION SYSTEMS 524
13.2.8 ANUMANA, INC. 525
13.2.9 MEMORA HEALTH INC. 526
13.2.10 MEDIVIEW XR, INC. 527
14 APPENDIX 528
14.1 DISCUSSION GUIDE 528
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 534
14.3 CUSTOMIZATION OPTIONS 536
14.4 RELATED REPORTS 537
14.5 AUTHOR DETAILS 538
LIST OF TABLES
TABLE 1 CLINICAL INFORMATICS MARKET: INCLUSIONS & EXCLUSIONS 43
TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 45
TABLE 3 CLINICAL INFORMATICS MARKET: FACTOR ANALYSIS 58
TABLE 4 CLINICAL INFORMATICS MARKET: MARKET SIZING ASSUMPTIONS 62
TABLE 5 CLINICAL INFORMATICS MARKET: RISK ASSESSMENT 63
TABLE 6 CLINICAL INFORMATICS MARKET: IMPACT ANALYSIS 76
TABLE 7 RECENT DEVELOPMENTS FOR TELEHEALTH EXPANSION,
JANUARY 2024–DECEMBER 2024 78
TABLE 8 RECENT DEVELOPMENTS FOR VIRTUAL CLINICAL & NURSING ASSISTANTS, JANUARY 2023–DECEMBER 2024 89
TABLE 9 TOP 30 HEALTHCARE DATA BREACHES IN US (2011−2024) 93
TABLE 10 CLINICAL INFORMATICS MARKET: ROLE IN ECOSYSTEM 101
TABLE 11 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 108
TABLE 12 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 109
TABLE 13 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 110
TABLE 14 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 111
TABLE 15 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 111
TABLE 16 REGULATORY SCENARIO OF NORTH AMERICA 111
TABLE 17 REGULATORY SCENARIO OF EUROPE 113
TABLE 18 REGULATORY SCENARIO OF ASIA PACIFIC 113
TABLE 19 REGULATORY SCENARIO OF MIDDLE EAST & AFRICA 115
TABLE 20 REGULATORY SCENARIO OF LATIN AMERICA 115
TABLE 21 INDICATIVE PRICE OF EHR SOLUTIONS, BY COMPONENT (2023) 117
TABLE 22 INDICATIVE PRICE OF CLINICAL DECISION SUPPORT SYSTEMS,
BY PRODUCT (2023) 118
TABLE 23 INDICATIVE PRICE OF HCIT INTEGRATION SOLUTIONS, BY COMPONENT (2023) 119
TABLE 24 INDICATIVE PRICE OF CLINICAL INFORMATICS SOLUTIONS, BY REGION (2023) 120
TABLE 25 CLINICAL INFORMATICS MARKET: PORTER’S FIVE FORCES ANALYSIS 121
TABLE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF
TOP THREE END USERS (%) 123
TABLE 27 KEY BUYING CRITERIA FOR TOP THREE END USERS 124
TABLE 28 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES
FOR CLINICAL INFORMATICS 126
TABLE 29 CLINICAL INFORMATICS MARKET: LIST OF PATENTS/PATENT APPLICATIONS 128
TABLE 30 UNMET NEEDS IN CLINICAL INFORMATICS MARKET 130
TABLE 31 END-USER EXPECTATIONS IN CLINICAL INFORMATICS MARKET 131
TABLE 32 CLINICAL INFORMATICS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 132
TABLE 33 CASE STUDY 1: TRANSFORMING CLINICAL INFORMATICS AT CORNWALL COMMUNITY HOSPITAL 133
TABLE 34 CASE STUDY 2: GRANGER MEDICAL CLINIC’S FOCUS ON GAINING EFFICIENT HEALTHCARE OPERATIONS 134
TABLE 35 CASE STUDY 3: IMPROVEMENTS OF IMAGING EFFICIENCY BY OVERCOMING REPORTING & VISUALIZATION BARRIERS 135
TABLE 36 CLINICAL INFORMATICS MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 147
TABLE 37 CLINICAL INFORMATICS MARKET FOR ELECTRONIC HEALTH RECORDS, BY REGION, 2022–2030 (USD MILLION) 149
TABLE 38 CLINICAL INFORMATICS MARKET FOR PRACTICE MANAGEMENT SYSTEMS,
BY REGION, 2022–2030 (USD MILLION) 150
TABLE 39 CLINICAL INFORMATICS MARKET FOR CLINICAL WORKFLOW MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 150
TABLE 40 CLINICAL INFORMATICS MARKET FOR CLINICAL WORKFLOW MANAGEMENT SYSTEMS, BY REGION, 2022–2030 (USD MILLION) 151
TABLE 41 WORKFLOW AUTOMATION SOLUTIONS MARKET, BY TYPE,
2022–2030 (USD MILLION) 152
TABLE 42 WORKFLOW AUTOMATION SOLUTIONS MARKET, BY REGION,
2022–2030 (USD MILLION) 152
TABLE 43 PATIENT FLOW MANAGEMENT SOLUTIONS MARKET, BY REGION,
2022–2030 (USD MILLION) 153
TABLE 44 CLINICIAN & STAFF SCHEDULING SOLUTIONS MARKET, BY REGION,
2022–2030 (USD MILLION) 154
TABLE 45 CLINICAL COMMUNICATION & COLLABORATION SOLUTIONS MARKET, BY REGION, 2022–2030 (USD MILLION) 155
TABLE 46 CLINICAL INFORMATICS MARKET FOR DIAGNOSTIC & IMAGING SOLUTIONS,
BY TYPE, 2022–2030 (USD MILLION) 156
TABLE 47 CLINICAL INFORMATICS MARKET FOR DIAGNOSTIC & IMAGING SOLUTIONS,
BY REGION, 2022–2030 (USD MILLION) 157
TABLE 48 MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY REGION,
2022–2030 (USD MILLION) 158
TABLE 49 PACS & VNA MARKET, BY REGION, 2022–2030 (USD MILLION) 159
TABLE 50 RADIOLOGY INFORMATION SYSTEMS MARKET, BY REGION,
2022–2030 (USD MILLION) 160
TABLE 51 LABORATORY INFORMATION SYSTEMS MARKET, BY REGION,
2022–2030 (USD MILLION) 161
TABLE 52 CLINICAL INFORMATICS MARKET FOR CLINICAL DECISION SUPPORT SYSTEMS,
BY REGION, 2022–2030 (USD MILLION) 163
TABLE 53 CLINICAL INFORMATICS MARKET FOR MEDICATION MANAGEMENT SYSTEMS,
BY TYPE, 2022–2030 (USD MILLION) 164
TABLE 54 CLINICAL INFORMATICS MARKET FOR MEDICATION MANAGEMENT SYSTEMS,
BY REGION, 2022–2030 (USD MILLION) 164
TABLE 55 EPRESCRIBING SOLUTIONS MARKET, BY REGION, 2022–2030 (USD MILLION) 165
TABLE 56 COMPUTERIZED PHYSICIAN ORDER ENTRY SYSTEMS MARKET, BY REGION,
2022–2030 (USD MILLION) 166
TABLE 57 PHARMACY INFORMATION SYSTEMS MARKET, BY REGION,
2022–2030 (USD MILLION) 167
TABLE 58 CLINICAL INFORMATICS MARKET FOR SPECIALTY INFORMATION MANAGEMENT SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 168
TABLE 59 CLINICAL INFORMATICS MARKET FOR SPECIALTY INFORMATION MANAGEMENT SOLUTIONS, BY REGION, 2022–2030 (USD MILLION) 169
TABLE 60 ONCOLOGY INFORMATION SYSTEMS MARKET, BY REGION,
2022–2030 (USD MILLION) 170
TABLE 61 CARDIOVASCULAR INFORMATION SYSTEMS MARKET, BY REGION,
2022–2030 (USD MILLION) 171
TABLE 62 OTHER SPECIALTY INFORMATION MANAGEMENT SOLUTIONS MARKET,
BY REGION, 2022–2030 (USD MILLION) 172
TABLE 63 CLINICAL INFORMATICS MARKET FOR TELEHEALTH & TELEMEDICINE SOLUTIONS, BY REGION, 2022–2030 (USD MILLION) 173
TABLE 64 CLINICAL INFORMATICS MARKET FOR INFECTION SURVEILLANCE SOLUTIONS,
BY REGION, 2022–2030 (USD MILLION) 174
TABLE 65 CLINICAL INFORMATICS MARKET FOR PATIENT PORTALS & ENGAGEMENT SOLUTIONS, BY REGION, 2022–2030 (USD MILLION) 175
TABLE 66 CLINICAL INFORMATICS MARKET FOR POPULATION HEALTH MANAGEMENT SOLUTIONS, BY REGION, 2022–2030 (USD MILLION) 176
TABLE 67 CLINICAL INFORMATICS MARKET FOR DATA ANALYTICS & REPORTING SOLUTIONS, BY REGION, 2022–2030 (USD MILLION) 177
TABLE 68 CLINICAL INFORMATICS MARKET FOR MOBILE HEALTH APPLICATIONS, BY REGION, 2022–2030 (USD MILLION) 178
TABLE 69 CLINICAL INFORMATICS MARKET FOR HCIT INTEGRATION & INTEROPERABILITY SYSTEMS, BY REGION, 2022–2030 (USD MILLION) 179
TABLE 70 CLINICAL INFORMATICS MARKET FOR OTHER FUNCTIONS, BY REGION,
2022–2030 (USD MILLION) 180
TABLE 71 CLINICAL INFORMATICS MARKET, BY DEPLOYMENT MODEL,
2022–2030 (USD MILLION) 182
TABLE 72 CLOUD-BASED CLINICAL INFORMATICS SOLUTIONS MARKET, BY REGION,
2022–2030 (USD MILLION) 183
TABLE 73 ON-PREMISE CLINICAL INFORMATICS SOLUTIONS MARKET, BY REGION,
2022–2030 (USD MILLION) 185
TABLE 74 HYBRID CLINICAL INFORMATICS SOLUTIONS MARKET, BY REGION,
2022–2030 (USD MILLION) 186
TABLE 75 CLINICAL INFORMATICS MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 188
TABLE 76 CLINICAL INFORMATICS SOFTWARE OFFERED BY KEY MARKET PLAYERS 189
TABLE 77 CLINICAL INFORMATICS MARKET FOR SOFTWARE, BY TYPE,
2022–2030 (USD MILLION) 191
TABLE 78 CLINICAL INFORMATICS MARKET FOR SOFTWARE, BY REGION,
2022–2030 (USD MILLION) 191
TABLE 79 CLINICAL INFORMATICS MARKET FOR STANDALONE SOFTWARE, BY REGION, 2022–2030 (USD MILLION) 192
TABLE 80 CLINICAL INFORMATICS MARKET FOR INTEGRATED SOFTWARE, BY REGION, 2022–2030 (USD MILLION) 193
TABLE 81 SERVICES OFFERED BY KEY MARKET PLAYERS 195
TABLE 82 CLINICAL INFORMATICS MARKET FOR SERVICES, BY REGION,
2022–2030 (USD MILLION) 196
TABLE 83 CLINICAL INFORMATICS MARKET, BY THERAPEUTIC AREA,
2022–2030 (USD MILLION) 198
TABLE 84 INDICATIVE LIST OF COMPANIES OFFERING ONCOLOGY
CLINICAL INFORMATICS SOLUTIONS 200
TABLE 85 CLINICAL INFORMATICS MARKET FOR ONCOLOGY, BY REGION,
2022–2030 (USD MILLION) 200
TABLE 86 CLINICAL INFORMATICS MARKET FOR CARDIOLOGY, BY REGION,
2022–2030 (USD MILLION) 201
TABLE 87 CLINICAL INFORMATICS MARKET FOR NEUROLOGY, BY REGION,
2022–2030 (USD MILLION) 202
TABLE 88 CLINICAL INFORMATICS MARKET FOR RESPIRATORY DISEASES, BY REGION, 2022–2030 (USD MILLION) 204
TABLE 89 CLINICAL INFORMATICS MARKET FOR IMMUNOLOGY, BY REGION,
2022–2030 (USD MILLION) 205
TABLE 90 CLINICAL INFORMATICS MARKET FOR METABOLIC DISORDERS, BY REGION,
2022–2030 (USD MILLION) 206
TABLE 91 CLINICAL INFORMATICS MARKET FOR INFECTIOUS DISEASES, BY REGION,
2022–2030 (USD MILLION) 207
TABLE 92 CLINICAL INFORMATICS MARKET FOR OTHER THERAPEUTIC AREAS,
BY REGION, 2022–2030 (USD MILLION) 209
TABLE 93 CLINICAL INFORMATICS MARKET, BY END USER, 2022–2030 (USD MILLION) 211
TABLE 94 CLINICAL INFORMATICS MARKET FOR HOSPITALS, BY REGION,
2022–2030 (USD MILLION) 213
TABLE 95 CLINICAL INFORMATICS MARKET FOR ASCS, ACCS, AND OTHER OUTPATIENT SETTINGS, BY REGION, 2022–2030 (USD MILLION) 214
TABLE 96 CLINICAL INFORMATICS MARKET FOR SPECIALTY CARE CENTERS, BY REGION, 2022–2030 (USD MILLION) 215
TABLE 97 CLINICAL INFORMATICS MARKET FOR HOME HEALTHCARE, LONG-TERM CARE, AND ASSISTED LIVING FACILITIES, BY REGION, 2022–2030 (USD MILLION) 217
TABLE 98 CLINICAL INFORMATICS MARKET FOR DIAGNOSTIC & IMAGING CENTERS,
BY REGION, 2022–2030 (USD MILLION) 218
TABLE 99 CLINICAL INFORMATICS MARKET FOR PHARMACIES, BY REGION,
2022–2030 (USD MILLION) 219
TABLE 100 CLINICAL INFORMATICS MARKET FOR OTHER END USERS, BY REGION,
2022–2030 (USD MILLION) 220
TABLE 101 CLINICAL INFORMATICS MARKET, BY REGION, 2022–2030 (USD MILLION) 222
TABLE 102 NORTH AMERICA: CLINICAL INFORMATICS MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 224
TABLE 103 NORTH AMERICA: CLINICAL INFORMATICS MARKET, BY FUNCTION,
2022–2030 (USD MILLION) 225
TABLE 104 NORTH AMERICA: CLINICAL INFORMATICS MARKET FOR CLINICAL WORKFLOW MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 226
TABLE 105 NORTH AMERICA: WORKFLOW AUTOMATION SOLUTIONS MARKET,
BY TYPE, 2022–2030 (USD MILLION) 226
TABLE 106 NORTH AMERICA: CLINICAL INFORMATICS MARKET FOR DIAGNOSTIC & IMAGING SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 226
TABLE 107 NORTH AMERICA: CLINICAL INFORMATICS MARKET FOR MEDICATION MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 227
TABLE 108 NORTH AMERICA: CLINICAL INFORMATICS MARKET FOR SPECIALTY INFORMATION MANAGEMENT SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 227
TABLE 109 NORTH AMERICA: CLINICAL INFORMATICS MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 228
TABLE 110 NORTH AMERICA: CLINICAL INFORMATICS MARKET FOR SOFTWARE, BY TYPE, 2022–2030 (USD MILLION) 228
TABLE 111 NORTH AMERICA: CLINICAL INFORMATICS MARKET, BY THERAPEUTIC AREA, 2022–2030 (USD MILLION) 229
TABLE 112 NORTH AMERICA: CLINICAL INFORMATICS MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 229
TABLE 113 NORTH AMERICA: CLINICAL INFORMATICS MARKET, BY END USER,
2022–2030 (USD MILLION) 230
TABLE 114 US: CLINICAL INFORMATICS MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 232
TABLE 115 US: CLINICAL INFORMATICS MARKET FOR CLINICAL WORKFLOW MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 233
TABLE 116 US: WORKFLOW AUTOMATION SOLUTIONS MARKET, BY TYPE,
2022–2030 (USD MILLION) 233
TABLE 117 US: CLINICAL INFORMATICS MARKET FOR DIAGNOSTIC & IMAGING SOLUTIONS,
BY TYPE, 2022–2030 (USD MILLION) 233
TABLE 118 US: CLINICAL INFORMATICS MARKET FOR MEDICATION MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 234
TABLE 119 US: CLINICAL INFORMATICS MARKET FOR SPECIALTY INFORMATION MANAGEMENT SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 234
TABLE 120 US: CLINICAL INFORMATICS MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 234
TABLE 121 US: CLINICAL INFORMATICS MARKET FOR SOFTWARE, BY TYPE,
2022–2030 (USD MILLION) 235
TABLE 122 US: CLINICAL INFORMATICS MARKET, BY THERAPEUTIC AREA,
2022–2030 (USD MILLION) 235
TABLE 123 US: CLINICAL INFORMATICS MARKET, BY DEPLOYMENT MODEL,
2022–2030 (USD MILLION) 236
TABLE 124 US: CLINICAL INFORMATICS MARKET, BY END USER, 2022–2030 (USD MILLION) 236
TABLE 125 CANADA: CLINICAL INFORMATICS MARKET, BY FUNCTION,
2022–2030 (USD MILLION) 238
TABLE 126 CANADA: CLINICAL INFORMATICS MARKET FOR CLINICAL WORKFLOW MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 238
TABLE 127 CANADA: WORKFLOW AUTOMATION SOLUTIONS MARKET, BY TYPE,
2022–2030 (USD MILLION) 239
TABLE 128 CANADA: CLINICAL INFORMATICS MARKET FOR DIAGNOSTIC & IMAGING SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 239
TABLE 129 CANADA: CLINICAL INFORMATICS MARKET FOR MEDICATION MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 240
TABLE 130 CANADA: CLINICAL INFORMATICS MARKET FOR SPECIALTY INFORMATION MANAGEMENT SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 240
TABLE 131 CANADA: CLINICAL INFORMATICS MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 240
TABLE 132 CANADA: CLINICAL INFORMATICS MARKET FOR SOFTWARE, BY TYPE,
2022–2030 (USD MILLION) 241
TABLE 133 CANADA: CLINICAL INFORMATICS MARKET, BY THERAPEUTIC AREA,
2022–2030 (USD MILLION) 241
TABLE 134 CANADA: CLINICAL INFORMATICS MARKET, BY DEPLOYMENT MODEL,
2022–2030 (USD MILLION) 242
TABLE 135 CANADA: CLINICAL INFORMATICS MARKET, BY END USER,
2022–2030 (USD MILLION) 242
TABLE 136 EUROPE: CLINICAL INFORMATICS MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 245
TABLE 137 EUROPE: CLINICAL INFORMATICS MARKET, BY FUNCTION,
2022–2030 (USD MILLION) 245
TABLE 138 EUROPE: CLINICAL INFORMATICS MARKET FOR CLINICAL WORKFLOW MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 246
TABLE 139 EUROPE: WORKFLOW AUTOMATION SOLUTIONS MARKET, BY TYPE,
2022–2030 (USD MILLION) 246
TABLE 140 EUROPE: CLINICAL INFORMATICS MARKET FOR DIAGNOSTIC & IMAGING SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 246
TABLE 141 EUROPE: CLINICAL INFORMATICS MARKET FOR MEDICATION MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 247
TABLE 142 EUROPE: CLINICAL INFORMATICS MARKET FOR SPECIALTY INFORMATION MANAGEMENT SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 247
TABLE 143 EUROPE: CLINICAL INFORMATICS MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 247
TABLE 144 EUROPE: CLINICAL INFORMATICS MARKET FOR SOFTWARE, BY TYPE,
2022–2030 (USD MILLION) 248
TABLE 145 EUROPE: CLINICAL INFORMATICS MARKET, BY THERAPEUTIC AREA,
2022–2030 (USD MILLION) 248
TABLE 146 EUROPE: CLINICAL INFORMATICS MARKET, BY DEPLOYMENT MODEL,
2022–2030 (USD MILLION) 249
TABLE 147 EUROPE: CLINICAL INFORMATICS MARKET, BY END USER,
2022–2030 (USD MILLION) 249
TABLE 148 UK: CLINICAL INFORMATICS MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 251
TABLE 149 UK: CLINICAL INFORMATICS MARKET FOR CLINICAL WORKFLOW MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 251
TABLE 150 UK: WORKFLOW AUTOMATION SOLUTIONS MARKET, BY TYPE,
2022–2030 (USD MILLION) 252
TABLE 151 UK: CLINICAL INFORMATICS MARKET FOR DIAGNOSTIC & IMAGING SOLUTIONS,
BY TYPE, 2022–2030 (USD MILLION) 252
TABLE 152 UK: CLINICAL INFORMATICS MARKET FOR MEDICATION MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 252
TABLE 153 UK: CLINICAL INFORMATICS MARKET FOR SPECIALTY INFORMATION MANAGEMENT SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 253
TABLE 154 UK: CLINICAL INFORMATICS MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 253
TABLE 155 UK: CLINICAL INFORMATICS MARKET FOR SOFTWARE, BY TYPE,
2022–2030 (USD MILLION) 253
TABLE 156 UK: CLINICAL INFORMATICS MARKET, BY THERAPEUTIC AREA,
2022–2030 (USD MILLION) 254
TABLE 157 UK: CLINICAL INFORMATICS MARKET, BY DEPLOYMENT MODEL,
2022–2030 (USD MILLION) 254
TABLE 158 UK: CLINICAL INFORMATICS MARKET, BY END USER, 2022–2030 (USD MILLION) 255
TABLE 159 GERMANY: CLINICAL INFORMATICS MARKET, BY FUNCTION,
2022–2030 (USD MILLION) 256
TABLE 160 GERMANY: CLINICAL INFORMATICS MARKET FOR CLINICAL WORKFLOW MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 257
TABLE 161 GERMANY: WORKFLOW AUTOMATION SOLUTIONS MARKET, BY TYPE,
2022–2030 (USD MILLION) 257
TABLE 162 GERMANY: CLINICAL INFORMATICS MARKET FOR DIAGNOSTIC & IMAGING SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 257
TABLE 163 GERMANY: CLINICAL INFORMATICS MARKET FOR MEDICATION MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 258
TABLE 164 GERMANY: CLINICAL INFORMATICS MARKET FOR SPECIALTY INFORMATION MANAGEMENT SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 258
TABLE 165 GERMANY: CLINICAL INFORMATICS MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 258
TABLE 166 GERMANY: CLINICAL INFORMATICS MARKET FOR SOFTWARE,
BY TYPE, 2022–2030 (USD MILLION) 259
TABLE 167 GERMANY: CLINICAL INFORMATICS MARKET, BY THERAPEUTIC AREA,
2022–2030 (USD MILLION) 259
TABLE 168 GERMANY: CLINICAL INFORMATICS MARKET, BY DEPLOYMENT MODEL,
2022–2030 (USD MILLION) 260
TABLE 169 GERMANY: CLINICAL INFORMATICS MARKET, BY END USER,
2022–2030 (USD MILLION) 260
TABLE 170 FRANCE: CLINICAL INFORMATICS MARKET, BY FUNCTION,
2022–2030 (USD MILLION) 262
TABLE 171 FRANCE: CLINICAL INFORMATICS MARKET FOR CLINICAL WORKFLOW MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 263
TABLE 172 FRANCE: WORKFLOW AUTOMATION SOLUTIONS MARKET, BY TYPE,
2022–2030 (USD MILLION) 263
TABLE 173 FRANCE: CLINICAL INFORMATICS MARKET FOR DIAGNOSTIC & IMAGING SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 263
TABLE 174 FRANCE: CLINICAL INFORMATICS MARKET FOR MEDICATION MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 264
TABLE 175 FRANCE: CLINICAL INFORMATICS MARKET FOR SPECIALTY INFORMATION MANAGEMENT SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 264
TABLE 176 FRANCE: CLINICAL INFORMATICS MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 264
TABLE 177 FRANCE: CLINICAL INFORMATICS MARKET FOR SOFTWARE, BY TYPE,
2022–2030 (USD MILLION) 265
TABLE 178 FRANCE: CLINICAL INFORMATICS MARKET, BY THERAPEUTIC AREA,
2022–2030 (USD MILLION) 265
TABLE 179 FRANCE: CLINICAL INFORMATICS MARKET, BY DEPLOYMENT MODEL,
2022–2030 (USD MILLION) 266
TABLE 180 FRANCE: CLINICAL INFORMATICS MARKET, BY END USER,
2022–2030 (USD MILLION) 266
TABLE 181 ITALY: CLINICAL INFORMATICS MARKET, BY FUNCTION,
2022–2030 (USD MILLION) 267
TABLE 182 ITALY: CLINICAL INFORMATICS MARKET FOR CLINICAL WORKFLOW MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 268
TABLE 183 ITALY: WORKFLOW AUTOMATION SOLUTIONS MARKET, BY TYPE,
2022–2030 (USD MILLION) 268
TABLE 184 ITALY: CLINICAL INFORMATICS MARKET FOR DIAGNOSTIC & IMAGING SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 268
TABLE 185 ITALY: CLINICAL INFORMATICS MARKET FOR MEDICATION MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 269
TABLE 186 ITALY: CLINICAL INFORMATICS MARKET FOR SPECIALTY INFORMATION MANAGEMENT SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 269
TABLE 187 ITALY: CLINICAL INFORMATICS MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 269
TABLE 188 ITALY: CLINICAL INFORMATICS MARKET FOR SOFTWARE, BY TYPE,
2022–2030 (USD MILLION) 270
TABLE 189 ITALY: CLINICAL INFORMATICS MARKET, BY THERAPEUTIC AREA,
2022–2030 (USD MILLION) 270
TABLE 190 ITALY: CLINICAL INFORMATICS MARKET, BY DEPLOYMENT MODEL,
2022–2030 (USD MILLION) 271
TABLE 191 ITALY: CLINICAL INFORMATICS MARKET, BY END USER,
2022–2030 (USD MILLION) 271
TABLE 192 SPAIN: CLINICAL INFORMATICS MARKET, BY FUNCTION,
2022–2030 (USD MILLION) 273
TABLE 193 SPAIN: CLINICAL INFORMATICS MARKET FOR CLINICAL WORKFLOW MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 273
TABLE 194 SPAIN: WORKFLOW AUTOMATION SOLUTIONS MARKET, BY TYPE,
2022–2030 (USD MILLION) 274
TABLE 195 SPAIN: CLINICAL INFORMATICS MARKET FOR DIAGNOSTIC & IMAGING SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 274
TABLE 196 SPAIN: CLINICAL INFORMATICS MARKET FOR MEDICATION MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 274
TABLE 197 SPAIN: CLINICAL INFORMATICS MARKET FOR SPECIALTY INFORMATION MANAGEMENT SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 275
TABLE 198 SPAIN: CLINICAL INFORMATICS MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 275
TABLE 199 SPAIN: CLINICAL INFORMATICS MARKET FOR SOFTWARE, BY TYPE
2022–2030 (USD MILLION) 275
TABLE 200 SPAIN: CLINICAL INFORMATICS MARKET, BY THERAPEUTIC AREA,
2022–2030 (USD MILLION) 276
TABLE 201 SPAIN: CLINICAL INFORMATICS MARKET, BY DEPLOYMENT MODEL,
2022–2030 (USD MILLION) 276
TABLE 202 SPAIN: CLINICAL INFORMATICS MARKET, BY END USER,
2022–2030 (USD MILLION) 277
TABLE 203 REST OF EUROPE: CLINICAL INFORMATICS MARKET, BY FUNCTION,
2022–2030 (USD MILLION) 278
TABLE 204 REST OF EUROPE: CLINICAL INFORMATICS MARKET FOR CLINICAL WORKFLOW MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 278
TABLE 205 REST OF EUROPE: WORKFLOW AUTOMATION SOLUTIONS MARKET, BY TYPE, 2022–2030 (USD MILLION) 279
TABLE 206 REST OF EUROPE: CLINICAL INFORMATICS MARKET FOR DIAGNOSTIC & IMAGING SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 279
TABLE 207 REST OF EUROPE: CLINICAL INFORMATICS MARKET FOR MEDICATION MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 279
TABLE 208 REST OF EUROPE: CLINICAL INFORMATICS MARKET FOR SPECIALTY INFORMATION MANAGEMENT SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 280
TABLE 209 REST OF EUROPE: CLINICAL INFORMATICS MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 280
TABLE 210 REST OF EUROPE: CLINICAL INFORMATICS MARKET FOR SOFTWARE, BY TYPE, 2022–2030 (USD MILLION) 280
TABLE 211 REST OF EUROPE: CLINICAL INFORMATICS MARKET, BY THERAPEUTIC AREA, 2022–2030 (USD MILLION) 281
TABLE 212 REST OF EUROPE: CLINICAL INFORMATICS MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 281
TABLE 213 REST OF EUROPE: CLINICAL INFORMATICS MARKET, BY END USER,
2022–2030 (USD MILLION) 282
TABLE 214 ASIA PACIFIC: CLINICAL INFORMATICS MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 285
TABLE 215 ASIA PACIFIC: CLINICAL INFORMATICS MARKET, BY FUNCTION,
2022–2030 (USD MILLION) 285
TABLE 216 ASIA PACIFIC: CLINICAL INFORMATICS MARKET FOR CLINICAL WORKFLOW MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 286
TABLE 217 ASIA PACIFIC: WORKFLOW AUTOMATION SOLUTIONS MARKET, BY TYPE,
2022–2030 (USD MILLION) 286
TABLE 218 ASIA PACIFIC: CLINICAL INFORMATICS MARKET FOR DIAGNOSTIC & IMAGING SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 286
TABLE 219 ASIA PACIFIC: CLINICAL INFORMATICS MARKET FOR MEDICATION MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 287
TABLE 220 ASIA PACIFIC: CLINICAL INFORMATICS MARKET FOR SPECIALTY INFORMATION MANAGEMENT SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 287
TABLE 221 ASIA PACIFIC: CLINICAL INFORMATICS MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 287
TABLE 222 ASIA PACIFIC: CLINICAL INFORMATICS MARKET FOR SOFTWARE, BY TYPE,
2022–2030 (USD MILLION) 288
TABLE 223 ASIA PACIFIC: CLINICAL INFORMATICS MARKET, BY THERAPEUTIC AREA,
2022–2030 (USD MILLION) 288
TABLE 224 ASIA PACIFIC: CLINICAL INFORMATICS MARKET, BY DEPLOYMENT MODEL,
2022–2030 (USD MILLION) 289
TABLE 225 ASIA PACIFIC: CLINICAL INFORMATICS MARKET, BY END USER,
2022–2030 (USD MILLION) 289
TABLE 226 JAPAN: CLINICAL INFORMATICS MARKET, BY FUNCTION,
2022–2030 (USD MILLION) 291
TABLE 227 JAPAN: CLINICAL INFORMATICS MARKET FOR CLINICAL WORKFLOW MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 291
TABLE 228 JAPAN: WORKFLOW AUTOMATION SOLUTIONS MARKET, BY TYPE,
2022–2030 (USD MILLION) 292
TABLE 229 JAPAN: CLINICAL INFORMATICS MARKET FOR DIAGNOSTIC & IMAGING SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 292
TABLE 230 JAPAN: CLINICAL INFORMATICS MARKET FOR MEDICATION MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 292
TABLE 231 JAPAN: CLINICAL INFORMATICS MARKET FOR SPECIALTY INFORMATION MANAGEMENT SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 293
TABLE 232 JAPAN: CLINICAL INFORMATICS MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 293
TABLE 233 JAPAN: CLINICAL INFORMATICS MARKET FOR SOFTWARE, BY TYPE,
2022–2030 (USD MILLION) 293
TABLE 234 JAPAN: CLINICAL INFORMATICS MARKET, BY THERAPEUTIC AREA,
2022–2030 (USD MILLION) 294
TABLE 235 JAPAN: CLINICAL INFORMATICS MARKET, BY DEPLOYMENT MODEL,
2022–2030 (USD MILLION) 294
TABLE 236 JAPAN: CLINICAL INFORMATICS MARKET, BY END USER,
2022–2030 (USD MILLION) 295
TABLE 237 CHINA: CLINICAL INFORMATICS MARKET, BY FUNCTION,
2022–2030 (USD MILLION) 296
TABLE 238 CHINA: CLINICAL INFORMATICS MARKET FOR CLINICAL WORKFLOW MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 297
TABLE 239 CHINA: WORKFLOW AUTOMATION SOLUTIONS MARKET, BY TYPE,
2022–2030 (USD MILLION) 297
TABLE 240 CHINA: CLINICAL INFORMATICS MARKET FOR DIAGNOSTIC & IMAGING SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 297
TABLE 241 CHINA: CLINICAL INFORMATICS MARKET FOR MEDICATION MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 298
TABLE 242 CHINA: CLINICAL INFORMATICS MARKET FOR SPECIALTY INFORMATION MANAGEMENT SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 298
TABLE 243 CHINA: CLINICAL INFORMATICS MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 298
TABLE 244 CHINA: CLINICAL INFORMATICS MARKET FOR SOFTWARE, BY TYPE,
2022–2030 (USD MILLION) 299
TABLE 245 CHINA: CLINICAL INFORMATICS MARKET, BY THERAPEUTIC AREA,
2022–2030 (USD MILLION) 299
TABLE 246 CHINA: CLINICAL INFORMATICS MARKET, BY DEPLOYMENT MODEL,
2022–2030 (USD MILLION) 300
TABLE 247 CHINA: CLINICAL INFORMATICS MARKET, BY END USER,
2022–2030 (USD MILLION) 300
TABLE 248 INDIA: CLINICAL INFORMATICS MARKET, BY FUNCTION,
2022–2030 (USD MILLION) 302
TABLE 249 INDIA: CLINICAL INFORMATICS MARKET FOR CLINICAL WORKFLOW MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 302
TABLE 250 INDIA: WORKFLOW AUTOMATION SOLUTIONS MARKET, BY TYPE,
2022–2030 (USD MILLION) 303
TABLE 251 INDIA: CLINICAL INFORMATICS MARKET FOR DIAGNOSTIC & IMAGING SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 303
TABLE 252 INDIA: CLINICAL INFORMATICS MARKET FOR MEDICATION MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 304
TABLE 253 INDIA: CLINICAL INFORMATICS MARKET FOR SPECIALTY INFORMATION MANAGEMENT SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 304
TABLE 254 INDIA: CLINICAL INFORMATICS MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 304
TABLE 255 INDIA: CLINICAL INFORMATICS MARKET FOR SOFTWARE, BY TYPE,
2022–2030 (USD MILLION) 305
TABLE 256 INDIA: CLINICAL INFORMATICS MARKET, BY THERAPEUTIC AREA,
2022–2030 (USD MILLION) 305
TABLE 257 INDIA: CLINICAL INFORMATICS MARKET, BY DEPLOYMENT MODEL,
2022–2030 (USD MILLION) 306
TABLE 258 INDIA: CLINICAL INFORMATICS MARKET, BY END USER,
2022–2030 (USD MILLION) 306
TABLE 259 REST OF ASIA PACIFIC: CLINICAL INFORMATICS MARKET, BY FUNCTION,
2022–2030 (USD MILLION) 308
TABLE 260 REST OF ASIA PACIFIC: CLINICAL INFORMATICS MARKET FOR CLINICAL WORKFLOW MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 308
TABLE 261 REST OF ASIA PACIFIC: WORKFLOW AUTOMATION SOLUTIONS MARKET, BY TYPE, 2022–2030 (USD MILLION) 309
TABLE 262 REST OF ASIA PACIFIC: CLINICAL INFORMATICS MARKET FOR DIAGNOSTIC & IMAGING SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 309
TABLE 263 REST OF ASIA PACIFIC: CLINICAL INFORMATICS MARKET FOR MEDICATION MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 310
TABLE 264 REST OF ASIA PACIFIC: CLINICAL INFORMATICS MARKET FOR SPECIALTY INFORMATION MANAGEMENT SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 310
TABLE 265 REST OF ASIA PACIFIC: CLINICAL INFORMATICS MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 311
TABLE 266 REST OF ASIA PACIFIC: CLINICAL INFORMATICS MARKET FOR SOFTWARE, BY TYPE, 2022–2030 (USD MILLION) 311
TABLE 267 REST OF ASIA PACIFIC: CLINICAL INFORMATICS MARKET, BY THERAPEUTIC AREA, 2022–2030 (USD MILLION) 312
TABLE 268 REST OF ASIA PACIFIC: CLINICAL INFORMATICS MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 312
TABLE 269 REST OF ASIA PACIFIC: CLINICAL INFORMATICS MARKET, BY END USER,
2022–2030 (USD MILLION) 313
TABLE 270 LATIN AMERICA: CLINICAL INFORMATICS MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 314
TABLE 271 LATIN AMERICA: CLINICAL INFORMATICS MARKET, BY FUNCTION,
2022–2030 (USD MILLION) 315
TABLE 272 LATIN AMERICA: CLINICAL INFORMATICS MARKET FOR CLINICAL WORKFLOW MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 315
TABLE 273 LATIN AMERICA: WORKFLOW AUTOMATION SOLUTIONS MARKET, BY TYPE,
2022–2030 (USD MILLION) 316
TABLE 274 LATIN AMERICA: CLINICAL INFORMATICS MARKET FOR DIAGNOSTIC & IMAGING SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 316
TABLE 275 LATIN AMERICA: CLINICAL INFORMATICS MARKET FOR MEDICATION MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 317
TABLE 276 LATIN AMERICA: CLINICAL INFORMATICS MARKET FOR SPECIALTY INFORMATION MANAGEMENT SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 317
TABLE 277 LATIN AMERICA: CLINICAL INFORMATICS MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 317
TABLE 278 LATIN AMERICA: CLINICAL INFORMATICS MARKET FOR SOFTWARE, BY TYPE, 2022–2030 (USD MILLION) 318
TABLE 279 LATIN AMERICA: CLINICAL INFORMATICS MARKET, BY THERAPEUTIC AREA,
2022–2030 (USD MILLION) 318
TABLE 280 LATIN AMERICA: CLINICAL INFORMATICS MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 319
TABLE 281 LATIN AMERICA: CLINICAL INFORMATICS MARKET, BY END USER,
2022–2030 (USD MILLION) 319
TABLE 282 BRAZIL: CLINICAL INFORMATICS MARKET, BY FUNCTION,
2022–2030 (USD MILLION) 321
TABLE 283 BRAZIL: CLINICAL INFORMATICS MARKET FOR CLINICAL WORKFLOW MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 321
TABLE 284 BRAZIL: WORKFLOW AUTOMATION SOLUTIONS MARKET, BY TYPE,
2022–2030 (USD MILLION) 322
TABLE 285 BRAZIL: CLINICAL INFORMATICS MARKET FOR DIAGNOSTIC & IMAGING SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 322
TABLE 286 BRAZIL: CLINICAL INFORMATICS MARKET FOR MEDICATION MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 323
TABLE 287 BRAZIL: CLINICAL INFORMATICS MARKET FOR SPECIALTY INFORMATION MANAGEMENT SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 323
TABLE 288 BRAZIL: CLINICAL INFORMATICS MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 323
TABLE 289 BRAZIL: CLINICAL INFORMATICS MARKET FOR SOFTWARE, BY TYPE,
2022–2030 (USD MILLION) 324
TABLE 290 BRAZIL: CLINICAL INFORMATICS MARKET, BY THERAPEUTIC AREA,
2022–2030 (USD MILLION) 324
TABLE 291 BRAZIL: CLINICAL INFORMATICS MARKET, BY DEPLOYMENT MODEL,
2022–2030 (USD MILLION) 325
TABLE 292 BRAZIL: CLINICAL INFORMATICS MARKET, BY END USER,
2022–2030 (USD MILLION) 325
TABLE 293 MEXICO: CLINICAL INFORMATICS MARKET, BY FUNCTION,
2022–2030 (USD MILLION) 326
TABLE 294 MEXICO: CLINICAL INFORMATICS MARKET FOR CLINICAL WORKFLOW MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 327
TABLE 295 MEXICO: WORKFLOW AUTOMATION SOLUTIONS MARKET, BY TYPE,
2022–2030 (USD MILLION) 327
TABLE 296 MEXICO: CLINICAL INFORMATICS MARKET FOR DIAGNOSTIC & IMAGING SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 327
TABLE 297 MEXICO: CLINICAL INFORMATICS MARKET FOR MEDICATION MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 328
TABLE 298 MEXICO: CLINICAL INFORMATICS MARKET FOR SPECIALTY INFORMATION MANAGEMENT SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 328
TABLE 299 MEXICO: CLINICAL INFORMATICS MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 328
TABLE 300 MEXICO: CLINICAL INFORMATICS MARKET FOR SOFTWARE, BY TYPE,
2022–2030 (USD MILLION) 329
TABLE 301 MEXICO: CLINICAL INFORMATICS MARKET, BY THERAPEUTIC AREA,
2022–2030 (USD MILLION) 329
TABLE 302 MEXICO: CLINICAL INFORMATICS MARKET, BY DEPLOYMENT MODEL,
2022–2030 (USD MILLION) 330
TABLE 303 MEXICO: CLINICAL INFORMATICS MARKET, BY END USER,
2022–2030 (USD MILLION) 330
TABLE 304 REST OF LATIN AMERICA: CLINICAL INFORMATICS MARKET, BY FUNCTION,
2022–2030 (USD MILLION) 331
TABLE 305 REST OF LATIN AMERICA: CLINICAL INFORMATICS MARKET FOR CLINICAL WORKFLOW MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 332
TABLE 306 REST OF LATIN AMERICA: WORKFLOW AUTOMATION SOLUTIONS MARKET,
BY TYPE, 2022–2030 (USD MILLION) 332
TABLE 307 REST OF LATIN AMERICA: CLINICAL INFORMATICS MARKET FOR DIAGNOSTIC & IMAGING SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 332
TABLE 308 REST OF LATIN AMERICA: CLINICAL INFORMATICS MARKET FOR MEDICATION MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 333
TABLE 309 REST OF LATIN AMERICA: CLINICAL INFORMATICS MARKET FOR SPECIALTY INFORMATION MANAGEMENT SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 333
TABLE 310 REST OF LATIN AMERICA: CLINICAL INFORMATICS MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 333
TABLE 311 REST OF LATIN AMERICA: CLINICAL INFORMATICS MARKET FOR SOFTWARE,
BY TYPE, 2022–2030 (USD MILLION) 334
TABLE 312 REST OF LATIN AMERICA: CLINICAL INFORMATICS MARKET, BY THERAPEUTIC AREA, 2022–2030 (USD MILLION) 334
TABLE 313 REST OF LATIN AMERICA: CLINICAL INFORMATICS MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 335
TABLE 314 REST OF LATIN AMERICA: CLINICAL INFORMATICS MARKET, BY END USER,
2022–2030 (USD MILLION) 335
TABLE 315 MIDDLE EAST & AFRICA: CLINICAL INFORMATICS MARKET, BY REGION,
2022–2030 (USD MILLION) 337
TABLE 316 MIDDLE EAST & AFRICA: CLINICAL INFORMATICS MARKET, BY FUNCTION,
2022–2030 (USD MILLION) 337
TABLE 317 MIDDLE EAST & AFRICA: CLINICAL INFORMATICS MARKET FOR CLINICAL WORKFLOW MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 338
TABLE 318 MIDDLE EAST & AFRICA: WORKFLOW AUTOMATION SOLUTIONS MARKET,
BY TYPE, 2022–2030 (USD MILLION) 338
TABLE 319 MIDDLE EAST & AFRICA: CLINICAL INFORMATICS MARKET FOR DIAGNOSTIC & IMAGING SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 338
TABLE 320 MIDDLE EAST & AFRICA: CLINICAL INFORMATICS MARKET FOR MEDICATION MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 339
TABLE 321 MIDDLE EAST & AFRICA: CLINICAL INFORMATICS MARKET FOR SPECIALTY INFORMATION MANAGEMENT SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 339
TABLE 322 MIDDLE EAST & AFRICA: CLINICAL INFORMATICS MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 339
TABLE 323 MIDDLE EAST & AFRICA: CLINICAL INFORMATICS MARKET FOR SOFTWARE,
BY TYPE, 2022–2030 (USD MILLION) 340
TABLE 324 MIDDLE EAST & AFRICA: CLINICAL INFORMATICS MARKET, BY THERAPEUTIC AREA, 2022–2030 (USD MILLION) 340
TABLE 325 MIDDLE EAST & AFRICA: CLINICAL INFORMATICS MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 341
TABLE 326 MIDDLE EAST & AFRICA: CLINICAL INFORMATICS MARKET, BY END USER,
2022–2030 (USD MILLION) 341
TABLE 327 GCC COUNTRIES: CLINICAL INFORMATICS MARKET, BY FUNCTION,
2022–2030 (USD MILLION) 343
TABLE 328 GCC COUNTRIES: CLINICAL INFORMATICS MARKET FOR CLINICAL WORKFLOW MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 343
TABLE 329 GCC COUNTRIES: WORKFLOW AUTOMATION SOLUTIONS MARKET, BY TYPE,
2022–2030 (USD MILLION) 344
TABLE 330 GCC COUNTRIES: CLINICAL INFORMATICS MARKET FOR DIAGNOSTIC & IMAGING SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 344
TABLE 331 GCC COUNTRIES: CLINICAL INFORMATICS MARKET FOR MEDICATION MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 345
TABLE 332 GCC COUNTRIES: CLINICAL INFORMATICS MARKET FOR SPECIALTY INFORMATION MANAGEMENT SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 345
TABLE 333 GCC COUNTRIES: CLINICAL INFORMATICS MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 345
TABLE 334 GCC COUNTRIES: CLINICAL INFORMATICS MARKET FOR SOFTWARE,
BY TYPE, 2022–2030 (USD MILLION) 346
TABLE 335 GCC COUNTRIES: CLINICAL INFORMATICS MARKET, BY THERAPEUTIC AREA,
2022–2030 (USD MILLION) 346
TABLE 336 GCC COUNTRIES: CLINICAL INFORMATICS MARKET, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 347
TABLE 337 GCC COUNTRIES: CLINICAL INFORMATICS MARKET, BY END USER,
2022–2030 (USD MILLION) 347
TABLE 338 REST OF THE MIDDLE EAST & AFRICA: CLINICAL INFORMATICS MARKET,
BY FUNCTION, 2022–2030 (USD MILLION) 348
TABLE 339 REST OF THE MIDDLE EAST & AFRICA: CLINICAL INFORMATICS MARKET FOR CLINICAL WORKFLOW MANAGEMENT SYSTEMS, BY TYPE,
2022–2030 (USD MILLION) 349
TABLE 340 REST OF THE MIDDLE EAST & AFRICA: WORKFLOW AUTOMATION SOLUTIONS MARKET, BY TYPE, 2022–2030 (USD MILLION) 349
TABLE 341 REST OF THE MIDDLE EAST & AFRICA: CLINICAL INFORMATICS MARKET FOR DIAGNOSTIC & IMAGING SOLUTIONS, BY TYPE, 2022–2030 (USD MILLION) 349
TABLE 342 REST OF THE MIDDLE EAST & AFRICA: CLINICAL INFORMATICS MARKET FOR MEDICATION MANAGEMENT SYSTEMS, BY TYPE, 2022–2030 (USD MILLION) 350
TABLE 343 REST OF THE MIDDLE EAST & AFRICA: CLINICAL INFORMATICS MARKET FOR SPECIALTY INFORMATION MANAGEMENT SOLUTIONS, BY TYPE,
2022–2030 (USD MILLION) 350
TABLE 344 REST OF THE MIDDLE EAST & AFRICA: CLINICAL INFORMATICS MARKET,
BY COMPONENT, 2022–2030 (USD MILLION) 350
TABLE 345 REST OF THE MIDDLE EAST & AFRICA: CLINICAL INFORMATICS MARKET FOR SOFTWARE, BY TYPE, 2022–2030 (USD MILLION) 351
TABLE 346 REST OF THE MIDDLE EAST & AFRICA: CLINICAL INFORMATICS MARKET,
BY THERAPEUTIC AREA, 2022–2030 (USD MILLION) 351
TABLE 347 REST OF THE MIDDLE EAST & AFRICA: CLINICAL INFORMATICS MARKET,
BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION) 352
TABLE 348 REST OF THE MIDDLE EAST & AFRICA: CLINICAL INFORMATICS MARKET,
BY END USER, 2022–2030 (USD MILLION) 352
TABLE 349 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CLINICAL INFORMATICS MARKET, JANUARY 2021–DECEMBER 2024 354
TABLE 350 CLINICAL INFORMATICS MARKET: DEGREE OF COMPETITION 360
TABLE 351 CLINICAL INFORMATICS MARKET: REGIONAL FOOTPRINT, 2023 368
TABLE 352 CLINICAL INFORMATICS MARKET: FUNCTION FOOTPRINT, 2023 (1/5) 369
TABLE 353 CLINICAL INFORMATICS MARKET: FUNCTION FOOTPRINT, 2023 (2/5) 370
TABLE 354 CLINICAL INFORMATICS MARKET: FUNCTION FOOTPRINT (3/5) 371
TABLE 355 CLINICAL INFORMATICS MARKET: FUNCTION FOOTPRINT (4/5) 372
TABLE 356 CLINICAL INFORMATICS MARKET: FUNCTION FOOTPRINT (5/5) 373
TABLE 357 CLINICAL INFORMATICS MARKET: COMPONENT FOOTPRINT, 2023 374
TABLE 358 CLINICAL INFORMATICS MARKET: DEPLOYMENT MODEL FOOTPRINT, 2023 375
TABLE 359 CLINICAL INFORMATICS MARKET: END-USER FOOTPRINT, 2023 376
TABLE 360 CLINICAL INFORMATICS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 379
TABLE 361 CLINICAL INFORMATICS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY REGION 380
TABLE 362 CLINICAL INFORMATICS MARKET: PRODUCT LAUNCHES/APPROVALS/UPGRADES, JANUARY 2021–DECEMBER 2024 381
TABLE 363 CLINICAL INFORMATICS MARKET: DEALS, JANUARY 2021–DECEMBER 2024 383
TABLE 364 CLINICAL INFORMATICS MARKET: EXPANSIONS, JANUARY 2021–DECEMBER 2024 385
TABLE 365 CLINICAL INFORMATICS MARKET: OTHER DEVELOPMENTS,
JANUARY 2021–DECEMBER 2024 386
TABLE 366 UNITEDHEALTH GROUP: COMPANY OVERVIEW 387
TABLE 367 UNITEDHEALTH GROUP: PRODUCTS OFFERED 388
TABLE 368 UNITEDHEALTH GROUP: PRODUCT LAUNCHES/APPROVALS/UPGRADES,
JANUARY 2021–DECEMBER 2024 391
TABLE 369 UNITEDHEALTH GROUP: DEALS, JANUARY 2021–DECEMBER 2024 391
TABLE 370 ORACLE: COMPANY OVERVIEW 393
TABLE 371 ORACLE: PRODUCTS OFFERED 395
TABLE 372 ORACLE: PRODUCT LAUNCHES/APPROVALS/UPGRADES,
JANUARY 2021–DECEMBER 2024 398
TABLE 373 ORACLE: DEALS, JANUARY 2021–DECEMBER 2024 400
TABLE 374 ORACLE: CONTRACTS, JANUARY 2021–DECEMBER 2024 401
TABLE 375 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW 403
TABLE 376 EPIC SYSTEMS CORPORATION: PRODUCTS OFFERED 403
TABLE 377 EPIC SYSTEMS CORPORATION: PRODUCT LAUNCHES/APPROVALS/UPGRADES, JANUARY 2021–DECEMBER 2024 408
TABLE 378 EPIC SYSTEMS CORPORATION: DEALS, JANUARY 2021–DECEMBER 2024 409
TABLE 379 EPIC SYSTEMS CORPORATION: CONTRACTS, JANUARY 2021–DECEMBER 2024 410
TABLE 380 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 412
TABLE 381 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED 414
TABLE 382 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES/APPROVALS/UPGRADES, JANUARY 2021–DECEMBER 2024 416
TABLE 383 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2021–DECEMBER 2024 417
TABLE 384 MCKESSON CORPORATION: COMPANY OVERVIEW 424
TABLE 385 MCKESSON CORPORATION: PRODUCTS OFFERED 425
TABLE 386 MCKESSON CORPORATION: DEALS, JANUARY 2021–DECEMBER 2024 427
TABLE 387 MCKESSON CORPORATION: EXPANSIONS, JANUARY 2021–DECEMBER 2024 428
TABLE 388 GE HEALTHCARE: COMPANY OVERVIEW 430
TABLE 389 GE HEALTHCARE: PRODUCTS OFFERED 432
TABLE 390 GE HEALTHCARE: PRODUCT LAUNCHES/APPROVALS/UPGRADES, JANUARY 2021–DECEMBER 2024 434
TABLE 391 GE HEALTHCARE: DEALS, JANUARY 2021–DECEMBER 2024 435
TABLE 392 COGNIZANT: COMPANY OVERVIEW 437
TABLE 393 COGNIZANT: PRODUCTS OFFERED 439
TABLE 394 COGNIZANT: PRODUCT LAUNCHES/APPROVALS/UPGRADES, JANUARY 2021–DECEMBER 2024 439
TABLE 395 COGNIZANT: DEALS, JANUARY 2021–DECEMBER 2024 440
TABLE 396 EXLSERVICE HOLDINGS, INC.: COMPANY OVERVIEW 441
TABLE 397 EXLSERVICE HOLDINGS, INC.: PRODUCTS OFFERED 443
TABLE 398 EXLSERVICE HOLDINGS, INC.: DEALS, JANUARY 2021–DECEMBER 2024 445
TABLE 399 ECLINICALWORKS: COMPANY OVERVIEW 446
TABLE 400 ECLINICALWORKS: PRODUCTS OFFERED 446
TABLE 401 ECLINICALWORKS: PRODUCT LAUNCHES/APPROVALS/UPGRADES,
JANUARY 2021–DECEMBER 2024 448
TABLE 402 ECLINICALWORKS: DEALS, JANUARY 2021–DECEMBER 2024 448
TABLE 403 MEDICAL INFORMATION TECHNOLOGY, INC.: COMPANY OVERVIEW 450
TABLE 404 MEDICAL INFORMATION TECHNOLOGY, INC.: PRODUCTS OFFERED 450
TABLE 405 MEDICAL INFORMATION TECHNOLOGY, INC.: PRODUCT LAUNCHES/APPROVALS/UPGRADES, JANUARY 2021–DECEMBER 2024 451
TABLE 406 MEDICAL INFORMATION TECHNOLOGY, INC.: DEALS,
JANUARY 2021–DECEMBER 2024 452
TABLE 407 MEDICAL INFORMATION TECHNOLOGY, INC.: CONTRACTS,
JANUARY 2021–DECEMBER 2024 453
TABLE 408 MEDICAL INFORMATION TECHNOLOGY, INC.: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2024 455
TABLE 409 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 456
TABLE 410 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED 458
TABLE 411 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES/APPROVALS/UPGRADES, JANUARY 2021–DECEMBER 2024 459
TABLE 412 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2021–DECEMBER 2024 459
TABLE 413 TRUBRIDGE: COMPANY OVERVIEW 462
TABLE 414 TRUBRIDGE: PRODUCTS OFFERED 464
TABLE 415 TRUBRIDGE: PRODUCT LAUNCHES/APPROVALS/UPGRADES, JANUARY 2021–DECEMBER 2024 465
TABLE 416 TRUBRIDGE: DEALS, JANUARY 2021–DECEMBER 2024 465
TABLE 417 TRUBRIDGE: OTHER DEVELOPMENTS, JANUARY 2021–DECEMBER 2024 466
TABLE 418 VERADIGM LLC: COMPANY OVERVIEW 467
TABLE 419 VERADIGM LLC: PRODUCTS OFFERED 469
TABLE 420 VERADIGM LLC: DEALS, JANUARY 2021–DECEMBER 2024 470
TABLE 421 ADVANCEDMD, INC.: COMPANY OVERVIEW 471
TABLE 422 ADVANCEDMD, INC.: PRODUCTS OFFERED 472
TABLE 423 ADVANCEDMD, INC.: PRODUCT LAUNCHES/APPROVALS/UPGRADES, JANUARY 2021–DECEMBER 2024 473
TABLE 424 ADVANCEDMD, INC.: OTHER DEVELOPMENTS, JANUARY 2021–DECEMBER 2024 474
TABLE 425 ATHENAHEALTH, INC.: COMPANY OVERVIEW 475
TABLE 426 ATHENAHEALTH, INC.: PRODUCTS OFFERED 475
TABLE 427 ATHENAHEALTH, INC.: PRODUCT LAUNCHES/APPROVALS/UPGRADES,
JANUARY 2021–DECEMBER 2024 476
TABLE 428 ATHENAHEALTH, INC.: DEALS, JANUARY 2021–DECEMBER 2024 477
TABLE 429 ATHENAHEALTH, INC.: CONTRACTS, JANUARY 2021–DECEMBER 2024 479
TABLE 430 MERATIVE: COMPANY OVERVIEW 481
TABLE 431 MERATIVE: PRODUCTS OFFERED 482
TABLE 432 MERATIVE: PRODUCT LAUNCHES/APPROVALS/UPGRADES,
JANUARY 2021–DECEMBER 2024 483
TABLE 433 MERATIVE: DEALS, JANUARY 2021–DECEMBER 2024 484
TABLE 434 MERATIVE: OTHER DEVELOPMENTS, JANUARY 2021–DECEMBER 2024 484
TABLE 435 NVIDIA CORPORATION: COMPANY OVERVIEW 485
TABLE 436 NVIDIA CORPORATION: PRODUCTS OFFERED 487
TABLE 437 NVIDIA CORPORATION: PRODUCT LAUNCHES/APPROVALS/UPGRADES,
JANUARY 2021–NOVEMBER 2024 488
TABLE 438 NVIDIA CORPORATION: DEALS, JANUARY 2021–NOVEMBER 2024 488
TABLE 439 AGFA HEALTHCARE: COMPANY OVERVIEW 490
TABLE 440 AGFA HEALTHCARE: PRODUCTS OFFERED 490
TABLE 441 AGFA HEALTHCARE: PRODUCT LAUNCHES/APPROVALS/UPGRADES, JANUARY 2021–DECEMBER 2024 491
TABLE 442 AGFA HEALTHCARE: DEALS, JANUARY 2021–DECEMBER 2024 491
TABLE 443 NXGN MANAGEMENT, LLC: COMPANY OVERVIEW 492
TABLE 444 NXGN MANAGEMENT, LLC: PRODUCTS OFFERED 492
TABLE 445 NXGN MANAGEMENT, LLC: PRODUCT LAUNCHES/APPROVALS/UPGRADES, JANUARY 2021–DECEMBER 2024 493
TABLE 446 NXGN MANAGEMENT, LLC.: DEALS, JANUARY 2021–DECEMBER 2024 494
TABLE 447 NXGN MANAGEMENT, LLC: EXPANSIONS, JANUARY 2021–DECEMBER 2024 495
TABLE 448 NXGN MANAGEMENT, LLC.: CONTRACTS, JANUARY 2021–DECEMBER 2024 496
TABLE 449 INTERSYSTEMS CORPORATION: COMPANY OVERVIEW 498
TABLE 450 INTERSYSTEMS CORPORATION: PRODUCTS OFFERED 499
TABLE 451 INTERSYSTEMS CORPORATION: PRODUCT LAUNCHES/APPROVALS/UPGRADES, JANUARY 2021–DECEMBER 2024 500
TABLE 452 INTERSYSTEMS CORPORATION: DEALS, JANUARY 2021–DECEMBER 2024 501
TABLE 453 DEDALUS S.P.A.: COMPANY OVERVIEW 502
TABLE 454 DEDALUS S.P.A.: PRODUCTS OFFERED 502
TABLE 455 DEDALUS S.P.A.: DEALS, JANUARY 2021–DECEMBER 2024 503
TABLE 456 IQVIA INC.: COMPANY OVERVIEW 505
TABLE 457 IQVIA INC.: PRODUCTS OFFERED 507
TABLE 458 IQVIA INC.: PRODUCT LAUNCHES/APPROVALS/UPGRADES,
JANUARY 2021–DECEMBER 2024 508
TABLE 459 SAS INSTITUTE INC.: COMPANY OVERVIEW 509
TABLE 460 SAS INSTITUTE INC.: PRODUCTS OFFERED 509
TABLE 461 SAS INSTITUTE INC.: PRODUCT LAUNCHES/APPROVALS/UPGRADES, JANUARY 2021–DECEMBER 2024 510
TABLE 462 SAS INSTITUTE INC.: DEALS, JANUARY 2021–DECEMBER 2024 510
TABLE 463 WIPRO: COMPANY OVERVIEW 511
TABLE 464 WIPRO: PRODUCTS OFFERED 513
TABLE 465 WIPRO: DEALS, JANUARY 2021–DECEMBER 2024 514
TABLE 466 HEALTH CATALYST: COMPANY OVERVIEW 515
TABLE 467 HEALTH CATALYST: PRODUCTS OFFERED 516
TABLE 468 HEALTH CATALYST: DEALS, JANUARY 2021–DECEMBER 2024 517
TABLE 469 TEMPUS: COMPANY OVERVIEW 518
TABLE 470 PRACTICE FUSION, INC.: COMPANY OVERVIEW 519
TABLE 471 MEDEANALYTICS, INC.: COMPANY OVERVIEW 520
TABLE 472 MEDECISION: COMPANY OVERVIEW 521
TABLE 473 CHARTIS: COMPANY OVERVIEW 522
TABLE 474 ALLARA HEALTH: COMPANY OVERVIEW 523
TABLE 475 SURGICAL INFORMATION SYSTEMS: COMPANY OVERVIEW 524
TABLE 476 ANUMANA, INC.: COMPANY OVERVIEW 525
TABLE 477 MEMORA HEALTH INC.: COMPANY OVERVIEW 526
TABLE 478 MEDIVIEW XR, INC.: COMPANY OVERVIEW 527
LIST OF FIGURES
FIGURE 1 CLINICAL INFORMATICS MARKET: SEGMENTS CONSIDERED &
GEOGRAPHICAL SPREAD 42
FIGURE 2 CLINICAL INFORMATICS MARKET: YEARS CONSIDERED 45
FIGURE 3 CLINICAL INFORMATICS MARKET: RESEARCH DESIGN 47
FIGURE 4 CLINICAL INFORMATICS MARKET: KEY DATA FROM SECONDARY SOURCES 49
FIGURE 5 CLINICAL INFORMATICS MARKET: KEY SOURCES FOR PRIMARY DATA 50
FIGURE 6 CLINICAL INFORMATICS MARKET: KEY DATA FROM PRIMARY SOURCES 51
FIGURE 7 CLINICAL INFORMATICS MARKET: KEY INDUSTRY INSIGHTS 52
FIGURE 8 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 52
FIGURE 9 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 53
FIGURE 10 CLINICAL INFORMATICS MARKET: SUPPLY-SIDE MARKET ESTIMATION 54
FIGURE 11 CLINICAL INFORMATICS MARKET: REVENUE ESTIMATION APPROACH 55
FIGURE 12 BOTTOM-UP APPROACH: END-USER SPENDING ON CLINICAL INFORMATICS 56
FIGURE 13 CLINICAL INFORMATICS MARKET: TOP-DOWN APPROACH 57
FIGURE 14 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES (2024–2030) 59
FIGURE 15 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 60
FIGURE 16 CLINICAL INFORMATICS MARKET: DATA TRIANGULATION 61
FIGURE 17 CLINICAL INFORMATICS MARKET, BY FUNCTION, 2024 VS. 2030 (USD MILLION) 65
FIGURE 18 CLINICAL INFORMATICS MARKET, BY THERAPEUTIC AREA,
2024 VS. 2030 (USD MILLION) 66
FIGURE 19 CLINICAL INFORMATICS MARKET, BY COMPONENT, 2024 VS. 2030 (USD MILLION) 67
FIGURE 20 CLINICAL INFORMATICS MARKET, BY DEPLOYMENT MODEL,
2024 VS. 2030 (USD MILLION) 68
FIGURE 21 CLINICAL INFORMATICS MARKET, BY END USER, 2024 VS. 2030 (USD MILLION) 69
FIGURE 22 CLINICAL INFORMATICS MARKET: REGIONAL SNAPSHOT 70
FIGURE 23 FOCUS ON REDUCING HEALTHCARE COSTS AND IMPROVING DATA STANDARDIZATION TO DRIVE MARKET 71
FIGURE 24 US AND HOSPITALS SEGMENTS ACCOUNTED FOR LARGEST MARKET
SHARE IN 2023 72
FIGURE 25 CHINA TO REGISTER HIGHEST CAGR DURING STUDY PERIOD 73
FIGURE 26 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES FROM
2024 TO 2030 74
FIGURE 27 CLINICAL INFORMATICS MARKET: DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES 75
FIGURE 28 HEALTH EXPENDITURE AS SHARE OF GDP, 2022 81
FIGURE 29 US: HOSPITAL & PHYSICIAN ADOPTION OF EHR, 2008–2021 82
FIGURE 30 US: MEDICARE-CERTIFIED ASCS, BY STATE (AS OF SEPTEMBER 2024) 85
FIGURE 31 WORLD POPULATION COVERAGE, BY MOBILE NETWORK TYPE (2015−2023) 86
FIGURE 32 WORLD POPULATION COVERAGE FOR MOBILE NETWORK TYPE, BY REGION (2023) 87
FIGURE 33 APPROVAL OF PERSONALIZED MEDICINES BY US FDA, 2015–2023 88
FIGURE 34 US: HEALTHCARE SECURITY BREACHES OF 500+ RECORDS, 2009–2024 92
FIGURE 35 US: MEDIAN HEALTHCARE DATA BREACH SIZE, 2009–2024 92
FIGURE 36 INDIVIDUALS AFFECTED BY HEALTHCARE SECURITY BREACHES IN US, 2009–2023 93
FIGURE 37 REVENUE SHIFT IN CLINICAL INFORMATICS MARKET 96
FIGURE 38 CLINICAL INFORMATICS MARKET: ECOSYSTEM ANALYSIS 100
FIGURE 39 CLINICAL INFORMATICS MARKET: VALUE CHAIN ANALYSIS (2023) 102
FIGURE 40 AVERAGE SELLING PRICE TREND OF KEY PLAYERS FOR EHR (2023) 116
FIGURE 41 CLINICAL INFORMATICS MARKET: PORTER’S FIVE FORCES ANALYSIS 121
FIGURE 42 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 123
FIGURE 43 KEY BUYING CRITERIA FOR TOP THREE END USERS 124
FIGURE 44 PATENT PUBLICATION TRENDS IN CLINICAL INFORMATICS MARKET, 2015–2024 125
FIGURE 45 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR “CLINICAL INFORMATICS” PATENTS (JANUARY 2015–NOVEMBER 2024) 125
FIGURE 46 LEADING PATENTS IN CLINICAL INFORMATICS MARKET
(JANUARY 2015–NOVEMBER 2024) 127
FIGURE 48 MARKET POTENTIAL OF AI/GENERATIVE AI CLINICAL INFORMATICS ACROSS INDUSTRIES 138
FIGURE 49 US: NEW CANCER CASES, 2024 199
FIGURE 50 NORTH AMERICA: CLINICAL INFORMATICS MARKET SNAPSHOT 223
FIGURE 51 EUROPE: CLINICAL INFORMATICS MARKET SNAPSHOT 244
FIGURE 52 ASIA PACIFIC: CLINICAL INFORMATICS MARKET SNAPSHOT 284
FIGURE 53 REVENUE ANALYSIS OF KEY PLAYERS IN CLINICAL INFORMATICS MARKET,
2019–2023 (USD MILLION) 359
FIGURE 54 MARKET SHARE ANALYSIS OF KEY PLAYERS IN CLINICAL
INFORMATICS MARKET, 2023 360
FIGURE 55 EV/EBITDA OF KEY VENDORS, 2024 362
FIGURE 56 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND A 5-YEAR STOCK BETA OF CLINICAL INFORMATICS VENDORS, 2024 363
FIGURE 57 CLINICAL INFORMATICS MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS 364
FIGURE 58 CLINICAL INFORMATICS MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2023 366
FIGURE 59 CLINICAL INFORMATICS MARKET: COMPANY FOOTPRINT, 2023 367
FIGURE 60 CLINICAL INFORMATICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 378
FIGURE 61 UNITEDHEALTH GROUP: COMPANY SNAPSHOT (2023) 388
FIGURE 62 ORACLE: COMPANY SNAPSHOT (2023) 394
FIGURE 63 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2023) 413
FIGURE 64 MCKESSON CORPORATION: COMPANY SNAPSHOT (2023) 425
FIGURE 65 GE HEALTHCARE: COMPANY SNAPSHOT (2023) 431
FIGURE 66 COGNIZANT: COMPANY SNAPSHOT (2023) 438
FIGURE 67 EXLSERVICE HOLDINGS, INC.: COMPANY SNAPSHOT (2023) 442
FIGURE 68 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2023) 457
FIGURE 69 TRUBRIDGE: COMPANY SNAPSHOT (2023) 463
FIGURE 70 VERADIGM LLC: COMPANY SNAPSHOT (2021) 468
FIGURE 71 NVIDIA CORPORATION: COMPANY SNAPSHOT (2023) 486
FIGURE 72 IQVIA INC.: COMPANY SNAPSHOT (2023) 506
FIGURE 73 WIPRO: COMPANY SNAPSHOT (2023) 512
FIGURE 74 HEALTH CATALYST: COMPANY SNAPSHOT (2023) 515
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 精密林業市場規模、シェア、動向、2030年までの世界予測 2025-11-05
- フィールドサービス管理市場規模、シェア、動向、2030年までの世界予測 2025-11-05
- 採血装置市場規模、シェア、動向、2030年までの世界予測 2025-11-04
- 車載半導体市場規模、シェア、動向、2030年までの世界予測 2025-11-04
- データセンターUPS市場規模、シェア、動向、2030年までの世界予測 2025-10-31